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Abstract 
Adequate fluid administration during and after cardiac surgery is essential to ensure 
adequate oxygen delivery to the tissues, while simultaneously avoiding the dangers of 
hypervolemia and fluid overload. In both cardiac and non-cardiac surgery there has been 
debate on what the best approach to fluid management is, what hemodynamic parameters 
should be used to assess fluid requirements, and what type of fluids should be used. 
There are several studies in non-cardiac surgery that examine these issues, while they are 
fewer in the field of cardiac surgery. An integrative review design was used to examine 
the current evidence on fluid management practices in cardiac surgery. Thirteen studies 
were included in this review. They included four studies of surveys on fluid management 
practices, eight studies that utilized goal directed therapy (GDT), and one observational 
study on fluid administration practices in cardiac surgical patients. The results showed 
that arterial blood pressure (ABP), central venous pressure (CVP), and echocardiography 
were used most often to monitor volume status. Crystalloids were used most frequently 
for volume replacement. In the studies utilizing GDT, fluid administration was often 
based on stroke volume variation (SVV) and cardiac index (CI) goals. A slight trend 
towards increased fluid administration was seen in the GDT groups. Fluid bolus volumes 
ranged from 100 to 500 ml. The GDT groups had a slight trend toward decreased length 
of both hospital and ICU stay. An important limitation of the review was that none of the 
studies were conducted in the United States of America.  
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An Integrative Review of Fluid Management in Cardiac Surgery 
Background/Statement of the Problem 
Fluid management in cardiac surgery is a crucial component of care. Fluid shifts 
and hypovolemia are common in the intraoperative and immediate postoperative period 
and may be caused by various factors that induce physiological alterations. Some of these 
factors include anesthetic agents, cardiopulmonary bypass (CPB), and/or blood loss 
(Norris, 1993). Adequate fluid resuscitation during and after cardiac surgery is essential 
to ensure adequate oxygen delivery to the tissues. It is important to provide enough fluid 
to maintain perfusion; at the same time, hypervolemia and fluid overload should be 
avoided. In both cardiac and non-cardiac surgeries there is debate on what hemodynamic 
parameters should be used to assess fluid requirements and responsiveness, what type of 
fluids should be used, and whether a restrictive or liberal approach improves outcomes 
(Bignami, Guarnieri & Gemma, 2017; Della Roca et al., 2014; Marik, Monnet, & Teboul, 
2011).  Some specialties such as thoracic surgery involving the lungs, generally use a 
restrictive approach to fluid management. This approach is based on studies that showed 
an increased incidence of pulmonary edema and acute lung injury in patients having 
surgery for lung cancer and post pneumonectomy, who received excessive intraoperative 
fluid infusion (Licker et al., 2003; Parquin, Mehiri, Herv & Lescot, 1996).  Multiple 
studies have also been conducted in non-cardiac surgeries comparing a restricted vs. 
liberal perioperative fluid administration approach. Some of these included 
pancreatectomy, abdominal vascular surgery, colonic surgery, lung resection, 
pancreaticoduodenectomy, and major abdominal surgery (González-Fajardo, Mengibar,  
Brizuela, Castrodeza, & Vaquero-Puerta, 2009; Grant et al., 2016; Holte et al., 2007; 
Matot et al.,2013; van Samkar et al., 2015; Vermeulen, Hofland, Legemate, & Ubbink, 
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2009). The results have been mixed, with some studies showing favorable outcomes with 
fluid restriction, some showing no significant difference and some having shown this 
approach to be harmful. While there are ample studies that compare a restricted vs. liberal 
approach in non-cardiac surgery, they are fewer in cardiac surgery (Mariscalco & 
Musumeci, 2014). Currently there are only two trials, both by Vretzakis and colleagues 
(2009; 2010), that assessed blood transfusion requirements when using a restricted vs. 
liberal perioperative intravenous fluid (IVF) approach in cardiac surgery patients. 
Goal directed therapy (GDT) is an approach that has been gaining support for 
several years and has been studied in both non-cardiac and cardiac surgeries. Goal 
directed therapy utilizes fluid management strategies that use patient-specific 
hemodynamic outcomes to optimize physiologic stability, cardiovascular volume, tissue 
oxygenation, nutrient delivery, microvascular flow, and end organ perfusion while 
minimizing complications associated with perioperative fluid volume depletion or 
overload (Trinooson & Gold, 2013). Some hemodynamic measurements commonly 
utilized in GDT include cardiac output (CO) and stroke volume (SV), left ventricular 
end-diastolic area that is measured by transesophageal echocardiography (TEE), SVV 
and pulse pressure variation (PPV) (Gutierrez, Moore, & Liu, 2013). There are several 
studies that have evaluated perioperative GDT therapy in both non-cardiac and cardiac 
patients. Some of these include GDT in off-pump coronary artery bypass graft (CABG), 
high risk CABG, abdominal surgery, high risk surgery and high risk cardiac surgery, 
(Kapoor, Magoon, Rawat, & Mehta, 2016; Osawa et al., 2016; Ramsingh, Sanghvi, 
Gamboa, Cannesson, & Applegate, 2013; Scheeren, Wiesenack, Gerlach, & Marx, 2013; 
Walker & Young, 2015). These studies compared a GDT approach to “usual or standard 
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care”; however, what constituted usual or standard care itself was variable. The 
hemodynamic parameters used, as well as the devices used to predict fluid needs in the 
GDT approach, also varied between studies.  
The advanced practice registered nurse (APRN) is often involved in the care of 
the patient undergoing cardiac surgery. The nurse anesthetist mostly cares for the patient 
in the preoperative and intraoperative phases of surgery, while the acute care nurse 
practitioner (NP), or the acute care clinical nurse specialist (CNS) predominantly manage 
postoperative care. Because fluid management is such a critical piece, it is essential for 
all APRNs to have a comprehensive understanding of this subject.   
An integrative review of literature was conducted  in order to gain a better 
understanding of fluid management practices involved in cardiac surgery. The purpose of 
this review was to explore and analyze the current evidence in published literature on 
fluid management in cardiac surgery patients. 
Next, the review of literature will be presented. 
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Literature Review 
The literature databases searched included CINAHL, Medline and PubMed.  Key 
search terms included combinations of fluid management, hypovolemia, fluid overload, 
hemodynamics, hemodynamic monitoring, surgery or operation or surgical procedure or 
surgical treatment, cardiac surgery, or heart surgery, or cardiovascular or coronary artery 
bypass or cardiopulmonary bypass and goal directed therapy. Searches were limited to 
the English language and the adult age group 19 years and older. No time limits were 
used for the literature review.  
Using EBSCO host with CINAHL and Medline databases, fluid management and 
surgery or operation or surgical procedure or surgical treatment yielded 267 articles from 
1975 to 2017. Fluid management and cardiac surgery, or heart surgery, or cardiovascular 
or coronary artery bypass or cardiopulmonary bypass yielded 93 articles from 1985 to 
2017. Goal directed therapy and cardiovascular or coronary artery bypass or 
cardiopulmonary bypass yielded 56 articles from 2004 to 2017. PubMed was also 
searched using similar terminologies. In addition, articles cited within those that were 
initially examined were also located and evaluated. 
Articles pertaining to fluid balance concepts, hemodynamic monitoring and 
parameters that guide fluid resuscitation, general fluid management approaches in adult 
cardiac and non-cardiac surgeries and different types of fluids used in perioperative fluid 
management were selected and used to build the literature review. Articles that studied 
fluid management in conjunction with very specific conditions, for example brain 
surgery, scoliosis, renal failure, heart failure, or those that also assessed drug effects such 
as those from the use of diuretics, were not included. Studies that did not have a direct 
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bearing on fluid management, for example those that studied cost or quality initiatives 
associated with fluid administration, were also excluded. 
Fluid Balance and Imbalance  
Many factors can alter the body’s fluid balance resulting in either hypovolemia or 
fluid overload. Hypovolemia is a clinical state in which significant loss of blood or 
plasma volume results in inadequate tissue perfusion. A reduction in blood volume and a 
fall in systolic pressure, triggers a sympathetic response that leads to peripheral 
vasoconstriction and tachycardia. Tachycardia and increased cardiac contractility can 
increase myocardial oxygen requirement. Blood flow to the skin and peripheral tissues is 
reduced to preserve perfusion of vital organs such as the brain, heart, liver, and kidneys. 
If tissue perfusion remains inadequate, a state of acidosis results from anaerobic 
metabolism, which leads to impaired performance of vital organs (Baskett, 1990).  Up to 
10% of the total blood volume can be lost without affecting either CO or arterial pressure. 
Greater than 10% loss diminishes CO due to decreased preload. Arterial pressure also 
declines with more than 20% loss of total blood volume (Kreimeier, 2000). Hypovolemia 
can be caused by various factors such as blood loss from trauma or surgery, dehydration 
from inadequate fluid intake, diarrhea, vomiting, fever, burns, diuretic therapy, adrenal 
insufficiency, and hyperglycemia (Grossman & Porth, 2014). 
 Fluid overload contributes to the pathogenesis of several clinically important 
complications including hypoxemia, myocardial edema and organ edema (Bellomo, 
Raman, & Ronco, 2001). Excessive fluid volume or fluid overload can be caused by 
disorders of renal function, heart failure, liver failure, corticosteroid excess, and 
excessive IVF and blood administration (Grossman & Porth, 2014). 
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Intravenous fluid administration is one of the most frequently used therapies 
provided in hospitals and is indicated in the management of hypovolemia, sepsis, 
perioperative correction of volume losses, hemodynamic alterations, or oliguria, that are 
believed to be volume responsive. When administered appropriately, IVF improve 
outcomes; however, inappropriate use can result in increased morbidity, length of hospital 
stay, and even mortality. Inappropriate IVF management can take the form of inadequate 
resuscitation, which can result in tissue hypoperfusion, or in over-resuscitation, which 
can lead to tissue edema and electrolyte imbalance (Hoste et. al., 2014). Appropriate 
intravenous fluid management requires appropriate hemodynamic monitoring to guide 
therapy and to avoid the risk for under as well as over resuscitation. Hemodynamic 
monitoring parameters and how they relate to fluid administration will be discussed in the 
next section. 
Hemodynamic Parameters to Guide Fluid Therapy 
The first step in hemodynamic management is to determine the adequacy of tissue 
and organ perfusion. Clinical indices of inadequate tissue perfusion may include low 
mean arterial pressure (MAP) and urine output, altered mentation, decreased capillary 
refill, skin mottling, cold extremities, increased blood lactate, altered arterial pH, 
decreased base excess, and bicarbonate values, and decreased mixed venous oxygen 
saturation (Schulman, 2002). Heart rate, blood pressure (BP), and urine output are the 
traditional clinical parameters used to determine decreased perfusion, however they may 
still be within normal range in early stages. As shock progresses and the body is unable to 
sustain a compensatory response, tachycardia, hypotension and oliguria may ensue. It is 
also important to note that the heart rate may not be appropriately elevated in the elderly, 
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or in those who take certain cardiac medications, while it may be elevated for reasons 
other than decreased perfusion, such as hyperthermia, pain or anxiety (Shulman). 
Vasoconstriction resulting from hypothermia, vasopressors, and catecholamine response 
due to stress or pain can increase the systemic vascular resistance (SVR) and therefore 
BP, regardless of actual intravascular volume. This is because the BP is a function of CO 
and SVR rather than tissue perfusion itself. Urine output can be an unreliable guide in the 
elderly, those with renal dysfunction, or hypothermic patients, as they may be unable to 
adequately concentrate urine, and consequently have an output that falsely appears to be 
adequate (Schulman). 
Fluid management is often the first intervention performed to improve tissue 
perfusion. However, it is important to remember that the goal of administering fluid is to 
improve the SV, which then improves tissue perfusion. Two concepts that are relevant to 
this discussion include fluid challenge and fluid or volume responsiveness. 
Fluid challenge. A fluid challenge is a method of identifying those patients who 
are likely to benefit from an increased intravenous volume in order to guide further 
volume resuscitation. If the fluid challenge results in an increase of SV and the CO by at 
least 10–15%  the patient is considered as being fluid responsive. The choice of fluid for 
a challenge may be a colloid, crystalloid, or blood, as indicated by clinical need. A 
volume of around 200 ml or 3 ml/kg given over about five minutes is generally 
considered standard (Cecconi, Parsons & Rhodes, 2011).  
Fluid responsiveness. Fluid responsiveness is the likelihood that a fluid 
challenge will result in increased SV (Marik, Monnet & Teboul, 2011). The only reason 
to fluid load a patient is to increase SV which then improves tissue perfusion. If the fluid 
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challenge does not increase SV, volume loading serves the patient no useful benefit and 
actually may be harmful, with excessive fluid resuscitation having been shown to be 
associated with increased complications, increased length of ICU and hospital stay, and 
increased mortality (Marik & Cavallazi, 2013; Marik, Monnet & Teboul, 2011).  
Practitioners have used different static and dynamic parameters to guide and 
predict fluid responsiveness over the years.  Static measurements of pressure were the 
first indices developed to assist with predicting fluid responsiveness. These 
measurements are obtained at a given condition or time point and are presumed to reflect 
preload. They include CVP and pulmonary artery occlusion pressures, as well as 
surrogates obtained through echocardiography including the inferior vena cava diameter 
and the end-diastolic volume (Mackenzie & Noble, 2014). 
Dynamic parameters are predictors of fluid responsiveness based on the heart- 
lung interactions and are determined by the changes in preload indices induced by 
intrathoracic pressure changes during mechanical ventilation. They include pulse pressure 
variation (PPV), stroke volume variation (SVV), and plethysmographic variability index 
(Mackenzie & Noble, 2014). A few of these measurements will be discussed below. 
Central venous pressure. CVP is very commonly used to assess fluid 
responsiveness and guide therapy, even though studies have shown that this measure has 
low predictive value for fluid responsiveness (Eskesen, Wetterslev & Perner, 2016; 
Marik, Baram, & Vahid, 2008; Marik & Cavallazi, 2013;). In the study by Eskesen et al. 
(2016), the investigators analyzed 1148 data sets of CVP and fluid responsiveness 
predictability. They grouped CVP ranges as low (< 8 mmHg), intermediate (8–12 
mmHg), and high (>12 mmHg), and assessed fluid responsiveness in relation to this 
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classification. The review included 51 studies, most of which were done in the ICU and 
the operating room setting. The individual patient data set, showed that 47 % of the CVP 
values were in the lower CVP subgroup, 30 % in the intermediate, and 23 % in the higher 
subgroups. When analyzing positive predictive value, the area under the receiver 
operating characteristic curve was 0.57 for the lower, 0.54 for the intermediate, and 0.56 
for the higher CVP subgroup (95 % CI [0.52, 0.62]). Thus, the results showed that the 
overall predictive value of CVP for fluid responsiveness was low. 
Pulse pressure variation. Ventilation-induced variation of pulse pressure and SV, 
which are dynamic parameters, are often used to predict fluid responsiveness. The 
increase in intrathoracic pressure during positive pressure inspiration causes a reduction 
of the preload, and therefore the SV. In patients who are hypovolemic, there is greater 
SVV and PPV. These methods do have limitations and cannot be used in patients with 
spontaneous respiration, low tidal volumes, arrhythmias, or in conditions where there is 
decreased lung compliance (Monnet, Marik, & Teboul, 2016).  
 Sá Malbouisson et al. (2017) studied the effect of PPV-guided intraoperative fluid 
loading in high-risk surgical patients on postoperative outcomes compared to the standard 
fluid resuscitation practice. This was a multicenter study that was conducted in three 
hospitals in São Paulo, Brazil. The patients were 60 years of age or older, with 
comorbidities, who were undergoing major surgery. The intervention group patients were 
managed with fluid loading based on PPV, while those in the control group were 
managed using CVP and MAP. There were 84 subjects in each group. The PPV-guided 
intraoperative fluid therapy was associated with a decrease in postoperative 
complications (OR: 0.59; 95% CI [0.35,0.99]). There was a significant reduction in the 
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postoperative and the hospital length of stay: eight days in the intervention group vs. 11 
days in the control group. The hazard ratio for the postoperative length of hospital stay 
was 0.6 (95% CI [0.42 - 0.88]). After 24 hours of ICU stay, significantly (p=0.027) fewer 
patients in the study group required continued mechanical ventilation compared to the 
control group. The volume of crystalloids infused was significantly (p=0.001) lower in 
the PPV group (median[IQR] 4500 ml [3200-6500]) compared to the control group (5000 
ml [3750-8862]). Significantly (p=0.01) fewer blood units were transfused during surgery 
in the PPV group (1.7 U [0.9-2.0 U]) compared to the study group (2.0 U [1.7-2.6 U]  
These findings suggested that the use of PPV can improve fluid management 
practices and improve patient outcomes; however as mentioned earlier, it cannot be used 
in patients with spontaneous respiration, low tidal volumes, arrhythmias, or in conditions 
where there is decreased lung compliance. 
Approaches to Fluid Replacement in the Surgical Patient 
Perioperative fluid management practices are highly variable and much discussion 
has been ongoing for years. There has been debate on what type of fluid; colloid or 
crystalloid, is most optimal; and whether a liberal or a restricted approach improves 
outcomes (Della Roca et al., 2014). Meta-analyses on the types of fluids have had 
varying conclusions, and there is no clarity in this regard. A liberal fluid administration 
approach was most commonly used in the past, because fluid depletion from fasting and 
insensible losses tended to be overestimated, and liberal fluid infusion was not considered 
as harmful (Myles et al., 2017). However, the perils of excessive fluid administration and 
overload are being increasingly recognized, and a restrictive approach is gaining favor 
(Myles et al.). Goal directed therapy is another fluid management approach that is 
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increasingly being studied and used in surgery.  Many studies have been conducted in 
various types of surgeries, comparing liberal, standard, and restrictive fluid approaches, 
and those using goal directed approaches. Some of these approaches and their evidence in 
literature, are described briefly below. 
Liberal or standard versus restricted approach. There are no standardized 
definitions for 'standard', 'restricted', or 'liberal' fluid regimens. Studies that compare 
these approaches have varying definitions Thus, some studies define as liberal, what 
other studies define as standard, and what some call standard, others refer to as 
restrictive. The results of studies comparing these approaches have been mixed, and it is 
difficult to determine if a liberal approach is safer than a restrictive approach, or whether 
neither of these is beneficial. A few studies comparing these approaches are described 
below. 
 A liberal approach was tested by Maharaj and colleagues (2005). They 
randomized 80 patients between the ages of 18 and 50 years, who were scheduled for 
laparoscopic gynecologic surgery to the study group, which was the large volume 
infusion group and to the control group. The control group received one preoperative 
fluid bolus of 3 ml/kg compound sodium lactate, whereas the large volume infusion 
group received a volume of 2 ml/kg/hour of fasting time. The overall incidence of 
postoperative nausea and vomiting in the first 72 postoperative hours was significantly 
reduced (p < 0.05, Fisher’s exact test) in the large volume group compared to the control. 
The large volume infusion group also had significantly decreased postoperative pain 
scores and required significantly less supplemental analgesia (p < 0.05, Fisher’s exact 
test). One of the limitations of this study is the fact that these patients had relatively long 
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fasting times, (12–13 hours), which occurred despite instructions to fast for six to eight 
hours from solids, and for four hours from fluids. This could account for the significant 
effect that the larger volume had on these outcomes. 
Varadhan and Lobo (2010) conducted a meta-analysis of IVF therapy in nine 
randomized controlled trials with 801 patients undergoing major elective open abdominal 
surgery. When restricted fluid regimens were compared with standard or liberal fluid 
regimens, there was no difference in post-operative complication rates or length of 
hospital stay. However, the researchers then reclassified and defined the fluid regimens. 
Restricted fluid therapy was fluid amount of less than 1.75 L/day; liberal fluid therapy or 
fluid overload was greater than 2.75 L/day; and both of these were considered to be a 
state of fluid imbalance. An amount between 1.75L to 2.75 L/day was considered 
balanced. With this reclassification, they found that the more balanced group had 
significantly fewer complications (risk ratio 0.59; 95% CI [0.44, 0.81]), p=0.0008) and 
shorter length of hospital stay (weighted mean difference -3.44 days; 95% CI [-6.33, -
0.54]), p=0.02) than those who received less than or more than the balanced amount. One 
drawback of this meta-analysis was that the complications are not detailed or specified. 
  Schol, Terink, Lancé, and Scheepers (2016) conducted a systematic review and 
meta-analysis that compared liberal vs. restrictive fluid approach in elective general 
surgery patients.  A total of 12 RCTs were included in the systematic review and 1397 
patients were analyzed with 693 in the restrictive protocol and 704 in the liberal protocol 
groups. Overall, the liberal group received more fluids than the restrictive group (M= 
4048 ml vs. M=2019 ml).  
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The total number of patients with a complication was significantly higher with the 
liberal fluid group (relative risk [RR] 0.65; 95% CI [0.55,0.78]). Percentages of bleeding, 
sepsis, and peritonitis did not differ between the two groups; however, pneumonia, 
cystitis, and wound infections were more common in the liberal group (RR 0.62; 95% CI 
[0.48,0.79]). More transfusions were needed in the liberal fluid group (RR 0.81;95% CI 
[0.66-0.99]), although the postoperative re-bleeding did not differ between groups (RR 
0.76; 95% CI [0.28,2.06]). One of the limitations of this systematic review and meta-
analysis was the heterogeneity of the included studies. There was a broad variety of 
participants with respect to age and comorbidities, as well as the type of surgery which 
could have had an influence on the results (Schol et al.). 
Jia and colleagues (2017) conducted a meta-analysis of studies that compared 
perioperative restrictive fluid therapy to liberal or conventional fluid therapy in patients 
undergoing major abdominal surgery. Specifically, they investigated the rate of post-
operative morbidity or complication rates, time to flatus, and the length of hospital stay. 
They included 13 RCTs, with 1052 patients, of whom 525 received restricted fluid 
regimens, and 527 patients received the standard or liberal or conventional fluid 
regimens. The types of surgery performed were heterogeneous across the studies and 
included hepato-gastroenterological and abdominal vascular procedures. 
The overall analysis revealed that the patients in the restricted group had a lower 
rate of complications in comparison with the patients in the control group; however, this 
did not reach statistical significance. Subgroup analysis showed that there was no 
significant difference in complication rates, time to flatus, or the length of stay in hepato-
gastroenterological surgeries. However, abdominal vascular surgery patients in the 
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restricted group had fewer overall complications; (pooled OR: 0.12; 95 % CI [0.03,0.47], 
p = 0.002) and a lower risk of cardiopulmonary complications (pooled OR: 0.09; 95 % CI 
[0.02, 0.43], p = 0.002). The vascular restricted fluid group also had shorter time to first 
flatus than the patients in the control group (pooled difference in the mean: −1.74; 95 % 
CI −2.12 to −1.35, p < 0.001), and a shorter length of hospital stay; (pooled difference in 
the mean: −4.31; 95 % CI [−6.64, −1.97], p < 0.001). 
Limitations in this study included significant heterogeneity with respect to the 
definitions of ‘restrictive’ and ‘standard’ fluid therapies. The total amount of 
perioperative fluid given ranged from 1.41 to 5.97 liters in the restrictive group, and from 
1.56 to 6.6 liters in the standard or liberal group. There was also heterogeneity in the 
types of surgery that were performed in the studies (Jia et al.). 
 Huang, Chua, Gill, and Samra (2017) conducted a systematic review and meta-
analysis on studies that compared different fluid regimens in patients undergoing 
pancreaticoduodenectomy.  The aim of the study was to examine the impact of 
perioperative fluid administration on perioperative outcomes after this procedure. Eleven 
studies; seven retrospective trials, and four RCTs comprising 2842 patients, were initially 
included in the review. Nine of these studies compared complications rates of high vs. 
low fluid volume regimen. Of these nine, two studies compared restrictive vs. standard 
regimens. Of the original 11 studies, seven studies were included in the meta-analysis and 
four were not included because of heterogeneity in reporting outcomes. There were no 
differences in length of hospital stay, or complications specific to the pancreas, 
pulmonary, cardiovascular, gastrointestinal, hepatobiliary, urogenital, wound, reoperation 
rate, and overall morbidity. There was also no difference in the 30 and 90-day mortality 
      15 
rates in low or high fluid groups. As in other meta-analyses, a limitation was the lack of 
uniformity in the categorization of what constituted restricted, standard, or liberal fluid 
regimens.  
           Goal directed fluid therapy. Trinooson and Gold (2013) described GDT as an 
approach that utilizes fluid management strategies that use patient-specific hemodynamic 
outcomes, such as a target SV or CO to optimize physiologic stability, cardiovascular 
volume, tissue oxygenation, nutrient delivery, microvascular flow, and end organ 
perfusion, while minimizing complications associated with perioperative fluid volume 
depletion or overload.  The concept of GDT has been around for more than thirty years; 
however, there is still no consensus as to what the most effective goals should be, or how 
best to assess and monitor fluid needs. After studying this topic for three years, Navarro 
and colleagues (2015), who were part of the International Fluid Optimization Group, 
concluded that GDT should at least have two steps. The first step is determining whether 
the patient requires hemodynamic support or augmentation of cardiovascular function. 
The second step is considering fluid bolus therapy if the patient is fluid responsive. 
Ripollés-Melchor and colleagues (2016) included the use of vasopressors and inotropes 
to the concept of GDT, and referred to the approach as goal-directed hemodynamic 
therapy (GDHT). They defined it as a method for determining the optimal dose of fluid 
therapy, inotropes, and vasopressors through a clinical algorithm to optimize cardiac 
output and delivery to the tissues in order to prevent situations of hypoperfusion and fluid 
overload. Over the years several studies as well as reviews have been performed of GDT 
in surgery.  A few of these are discussed below. 
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 Studies of GDT in surgical patients. A stratified meta-analysis of perioperative 
fluid management strategies in major surgery was conducted by Corcoran, Rhodes, 
Clarke, Myles, and Ho (2012). They hypothesized that while GDT tends to use greater 
amounts of fluid, similar to the liberal fluid administration approach, perioperative fluid 
therapy without hemodynamic goals is not equivalent to GDT.  To test this hypothesis, 
they conducted a stratified meta-analysis to assess whether these two approaches to 
managing perioperative fluid therapy would have different effects on the outcomes of 
patients undergoing major surgery. They included RCTs that evaluated a liberal vs. 
restrictive (LVR) fluid approach as compared to those that used GDT in patients 
undergoing major surgery. A therapy was considered GDT if it targeted a measurable 
hemodynamic variable, such as CO or PPV, rather than conventional measures such as 
arterial BP, urine output, or CVP. Trials that exclusively studied cardiac, neurosurgical, 
obstetric, trauma, burns, or critically ill patients were excluded. The primary outcome 
was postoperative mortality. Secondary outcomes were organ-specific complications, 
recovery of bowel function, and length of hospital stay.  
 Corcoran et al. (2012) grouped studies into two strata, the GDT stratum, and the 
LVR stratum. The GDT stratum included 24 studies with 3861 patients from 10 countries. 
The LVR stratum had 12 studies on LVR fluid therapy involving 1160 patients.  When the 
LVR stratum was analyzed, results showed that patients in the liberal group of the LVR 
stratum received larger amount of fluid (mean difference 1570 mL; 95% CI [986 , 2154]), 
had a higher risk of pneumonia (RR 2.2; 95% CI [1.0 to 4.5], p = 0.04), pulmonary 
edema (RR 3.8; 95% CI [1.1,13], p = 0.03), and a longer hospital stay (mean difference 2 
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days; 95% CI [0.5,3.4]) than those in the restrictive group. Bowel recovery also took 
longer in the liberal fluid group. 
  Comparison and analysis of GDT therapy to non-GDT in the second stratum 
showed the GDT group also received greater amounts of fluid as compared to the non-
GDT group (mean difference 467 mL; 95% CI [331, 603]), had shorter hospital length of 
stay (mean difference 2 days; 95% CI [1, 3]), lower rates of pneumonia (RR 0.7;95% CI 
[0.6, 0.9]) and renal complications (RR 0.7; 95% CI [0.5, 0.9]), and faster recovery of 
bowel function. 
 Finally, the GDT group was compared with the liberal fluid group. Both the 
liberal approach and the GDT approach used greater amounts of fluid than the 
comparison groups in each stratum. When the GDT group was compared to the liberal 
fluid therapy group, however, the liberal fluid approach was associated with an increased 
length of hospital stay (mean difference 4 days; 95% CI [3.4, 4.4]), increased time to first 
bowel movement (mean difference 2 days; 95% CI [1.3, 2.3]), and an increased risk of 
pneumonia (RR 3; 95% CI [1.8, 4.8]). Mortality, wound infection, and renal failure were 
not significantly different between liberal approach and GDT.  The study did not make 
any cross comparisons between the GDT group and the restricted fluid arm of the LVR 
stratum, so it is uncertain if GDT would have been considered superior or inferior to the 
restricted fluid approach. An important limitation of the study were the differences 
between the surgical case types, trial designs, and type of fluids used, which possibly 
resulted in heterogeneity of outcome results (Corcoran et al., 2012). 
Ripollés-Melchor et al., (2016), conducted a meta-analysis to assess the benefits 
of perioperative GDHT in terms of mortality and complications in adult patients 
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undergoing elective or emergency noncardiac surgery.  They selected for analysis RCTs 
in which GDHT was compared with conventional fluid therapy that used standard 
monitoring parameters. A total of 10 RCTs comprising1527 patients were included.  
The primary result that was analyzed was mortality. The analysis of all 10 RCTs, 
showed that the use of perioperative GDHT compared with conventional fluid therapy 
significantly reduced mortality (RR, 0.63; 95% CI [0.42,0.94] p = .02).  The secondary 
result was the number of patients with complications; only nine RCTs reported this 
number. There were no differences in the number of patients with complications between 
the GDHT and control groups (RR, 0.76; 95% CI [0.50,1.17] p = .21) Sub-analyses 
showed that the effects of GDHT on mortality were attributed to the GDHT trials that 
used supra-physiological goals, rather than physiological, and those that used 
perioperative GDHT rather than those than only used postoperative GDHT (Ripollés-
Melchor et al.). 
Some of the limitations included the fact that when the sensitivity analysis was 
performed including only the articles of higher methodological quality, it did not confirm 
the results that were previously obtained.  One of the studies used other interventions 
forming part of the enhanced recovery after surgery protocol, in addition to the GDHT. 
Many of the trials were single-center trials, and sample sizes were small, with only one 
trial having more than 100 patients per group (Ripollés-Melchor et al.). 
More recently, Sun, Chai, Pan, Romeiser, and Gan (2017) conducted a systematic 
review and meta-analysis to evaluate the effect of perioperative GDHT in comparison to 
conventional fluid therapy on postoperative recovery in adults undergoing major 
abdominal surgery. They included patients older than 16 years of age, who were 
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undergoing major abdominal surgery. Subjects either received perioperative fluids based 
on explicit measured goals for parameters such as cardiac output or index, SVV, PPV, 
mixed venous oxygen saturation, and lactate or were managed using conventional fluid 
administration strategies. In this case, standard parameters such as BP, heart rate, urine 
output, and CVP were used to guide fluid therapy. The GDHT group was the study group, 
while the conventional fluid group was the control group. The authors included 45 RCTs, 
which yielded 6344 patients, of whom 3406 received perioperative GDHT. The sample 
sizes of the RCTs ranged from 27 to 1994.  
The results showed that there was a significant reduction in short term mortality 
in the GDHT group (5.2) compared to the control group (7.0 %) RR 0.75: 95% CI 
[0.61,0.91] p=0.004.  The GDHT group also had an overall reduction in the rate of 
complications (RR 0.76; 95% CI [0.68,0.85] p<0.0001). Gastrointestinal function 
recovery was also significantly faster in the GDHT group. This was evidenced by 
shortened time to first flatus by 0.4 days (95% CI [−0.72, −0. 08], p=0.01) and the time to 
toleration of oral diet by 0.74 days (95% CI [−1.44 to −0.03] p<0.0001). Limitations of 
the meta-analysis included the fact that the GDHT strategy varied between trials, 
including fluid management, monitoring methods, therapeutic goals, and perioperative 
care environment. About half of the included studies had small sample sizes that were 
less than 100 and possibly lacked statistical power. Another limitation was that when the 
authors restricted the sensitivity analysis to studies with higher methodological quality, 
and those with larger sample size, the results were not confirmed (Sun et al.). 
Cardiac Surgery and Fluid Balance 
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Cardiac surgeries such as CABG, valve replacements, and aortic surgery are 
major procedures that are performed under general anesthesia. Cardiovascular operations 
and procedures totaled about 7.6 million in 2010 (American Heart Association, 2016). 
Morbidity and mortality in cardiac surgery is influenced by many factors such as whether 
the surgery was elective or emergent, with the latter increasing the risk for adverse 
outcome, the use of CPB vs. off-pump surgery, patient comorbidity, and various other 
factors.  Patient management and fluid therapy indications may also differ greatly from 
the OR to the ICU (Bignami, Guarnieri, & Gemma 2017). To maintain hemodynamic 
stability and adequate perfusion, patients often require treatment with fluids and 
vasopressors. Often, patients receive large amounts of fluids in the form of crystalloids, 
colloids and blood products intraoperatively as well as postoperatively. While patients 
require enough fluid to maintain adequate perfusion, excessive administration of fluid, as 
well as fluid shifts into the interstitial spaces, can lead to fluid overload in the 
postoperative phase.  
Fluid overload in cardiac surgery. Morin et al. (2011) conducted a prospective 
trial comparing the frequency of post-operative complications to fluid status in patients 
undergoing CABG surgery. A group of 109 adult patients undergoing CABG surgery in a 
Canadian hospital were recruited for the trial. The surgeries for all the patients were 
performed while on CPB. The researchers measured post-operative fluid overload by 
weight gain. The maximum weight gain over eight days was the value used for fluid 
overload. The investigators divided the weight gain into three categories: less than 1 kg; 1 
to 5 kg; and more than 5 kg. These categories were chosen arbitrarily by the investigators, 
and were not based on any definition in the literature. The complications were divided 
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into major and minor. Major complications included death, myocardial infarction, cardiac 
arrest, low cardiac output syndrome, cardiac tamponade, mediastinal exploration for 
bleeding, cerebral vascular accident, respiratory failure requiring prolonged intubation, 
renal failure, and deep sternal wound infection. Minor complications included atrial 
fibrillation, supra-ventricular tachycardia, new heart block, transient ischemic attack, 
delirium, pneumonia, leg wound infection, arm wound infection, and superficial sternal 
wound infection. 
There was no death in either group. Among the 20 patients who presented with a 
post-operative weight gain less than 1 kg, the counts of major, minor and no 
complications were respectively 1, 7, and 12. Out of 62 patients with a weight gain of 1 
to 5 kg, the counts of major, minor and no complications were 7, 21, and 34. In the group 
of 27 patients with a weight gain more than 5 kg., the counts of major, minor and no 
complications were 13, 8 and 6. A significant association was found between type of 
complication and fluid overload (p = 0.001), when the group that had weight gain more 
than 5 kg was compared with the other two groups. Between the groups that had less than 
1 kg and 1 to 5 kg weight gain, there was no significant difference. It is important to note 
that for patients with major complications, 43.36% were in NYHA class III or IV 
compared to 0% in NYHA class I or II. The median left ventricular ejection fraction was 
better (55%) in patients without complications, than patients who presented with minor or 
major complications (50%).  It is possible that these variables may have had a 
confounding effect on the results. The researchers suggested that the likely causes of fluid 
overload in cardiac surgery patients would include excessive perioperative fluid 
replacement and the systemic inflammatory reaction caused by CPB, which ultimately 
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results in increased capillary permeability and leakage of fluid in the extra-vascular 
space. They also endorsed a goal of administering minimal amount of fluids, that are 
adequate to maintain CO. The study itself however, while presenting the average amount 
of fluids used in the intraoperative and postoperative periods, did not seek to look for 
associations between volume administered and the fluid overload or complications. 
Fluid Management in the Cardiac Patient 
 Background. Patient responses to surgery and bypass can vary greatly based on 
multiple factors such as age, genetics, and comorbidities. The goal of postoperative 
hemodynamic management is the maintenance of adequate end-organ perfusion without 
overloading the heart. The first steps in this process are assessment and optimization of 
intravascular volume, which in the immediate postoperative period can be decreased by 
persistent third spacing, warming, diuresis, vasodilation, and bleeding. Patients with 
ventricular hypertrophy or diastolic dysfunction usually require greater filling pressures. 
Persistently low filling pressures despite aggressive fluid administration may be caused 
by bleeding or vasodilation. In such cases calculation of CO and SVR can help determine 
the cause (Khalpey, Schmitto, & Rawn, 2012).  
Fluid management in cardiac surgery involves decisions on when to administer 
fluid, how much to administer, as well as what type of fluid will be most beneficial. The 
timing and quantity of fluid to be administered is usually based on hemodynamic goals or 
indices such as the MAP, CVP or CO. However, the use of GDT with other indices such 
as the SVV are also being studied in cardiac surgery. With regard to the type of fluid, 
there is debate on the role of colloids vs. crystalloids, with numerous studies having been 
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conducted on their effects on outcomes. These areas will be discussed briefly in the 
following sections. 
Restrictive versus liberal approach. Vretzakis and colleagues (2009) assessed 
blood transfusion requirements when using a restricted vs. liberal perioperative IVF 
approach in cardiac surgery patients. Their hypothesis was that because hemodilution 
contributes to increased transfusion requirements, restriction of parenteral fluids in 
comparison to a liberal fluid administration policy would lead to less use of packed red 
cells (PRCs). They randomized 130 elective cardiac surgery patients to either a restricted 
or a liberal group. The authors found that intraoperatively transfused units were 
significantly (p < 0.0001) lower in the study group (0.32 +/- 0.77 units/patient) vs. the 
control group (1.26 +/- 1.05 units/ patient) The number of patients who were transfused 
was also significantly (p < 0.0001) lower in the study group (11 out of 65) vs. the control 
group (44 out of 65). The study was considered to be under-powered, so the same 
investigators did a second study on 192 elective cardiac surgery patients in 2010. They 
found similar results with this study as well.  Significantly (p < 0.04) fewer study group 
patients required transfusion in the study group (62 out of 100), compared to the control 
group (75 out of 92). They study group also received significantly (p < 0.0001) fewer 
PRC units (113) than the control group (176) (Vretzakis et. al., 2010). 
Goal directed therapy in cardiac surgery. Aya, Cecconi, Hamilton, and Rhodes 
(2013) conducted a meta-analysis to investigate whether a goal-directed hemodynamic 
approach to therapy in the perioperative period was associated with improved 
postoperative outcomes in cardiac surgical patients. The primary outcome was hospital 
mortality. The secondary outcome measures were postoperative morbidity and hospital 
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length of stay. They defined GDT as perioperative monitoring and manipulation of 
hemodynamic parameters to reach either normal or supra-normal pre-determined values. 
A total of five RCTs with 699 cardiac surgical patients were included in the meta-
analysis. 
There were 15 deaths in three studies, while two studies had no deaths. Analysis 
when combining all the groups showed that GDT did not reduce the mortality in the 
intervention group (pooled OR: 0.69; 95% CI [0.19, 2.56] p=0.58). When analyzing 
morbidity, there were 21 complications in the GDT group and 51 in the control group. In 
the pooled analysis, there was a significant reduction in the overall complication rate 
(OR:0.33; 95% CI [0.15,0.73] p=0.006). Hospital length of stay was significantly reduced 
in the GDT group, (MD: 22.21; 95% CI [23.84, 20.57] p=0.008). There were several 
study limitations including a small number of studies, inclusion of only single-center 
studies with small sample sizes, and heterogeneity in the therapeutic goals and 
hemodynamic parameters used (Aya et al.). 
Walker and Young (2015) designed a study to assess the effect of a postoperative 
GDT, or as they also called it, a “standardized hemodynamic protocol” (SHP), on the 
administration of fluid and vasoactive drugs after high-risk cardiac surgery. This study 
was conducted in a hospital in New Zealand. It was a single-center, interventional pilot 
study. It compared a prospective cohort of 40 high-risk cardiac surgical patients from 
2010 to 2011, with a retrospective cohort of 40 consecutive patients in 2009. The 
prospective cohort received SHP, while the retrospective cohort received usual care. A 
pulmonary artery catheter was inserted in all the study patients to guide therapy. The 
protocol guided administration of fluids, vasopressors, inotropes, and vasodilators to 
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target a cardiac index (CI) greater than 2 L/min/m2, a mixed venous oxygen saturation 
greater than 60%, and a MAP of 65 to 75 mmHg, for the first 12 hours of surgery. 
There was no significant difference in the duration of vasopressor infusion 
between the two groups. The SHP cohort received significantly (p <0.001) more fluid 
(4687±2284) in the first 12 hours postoperatively than the usual care cohort (1189±1344 
ml). The SHP cohort also had a significantly (p=0.049) higher rate of reintubation (4 in 
37 [10.8%]) vs. the usual care group (0 in 40 [0%]). There was one death from the SHP 
group, which was not deemed to be related to fluid overload. Some of the limitations of 
the study included the use of historical controls, which can inherently increase bias, the 
time span between the groups which could lead to change in staff or patterns of care, the 
small sample size, and the fact that this was a single center study (Walker & Young). 
Osawa and colleagues (2016) conducted a trial on 126 high risk patients 
undergoing coronary artery bypass surgery or valve repair. Subjects were randomized to 
the GDT arm which was guided by CO measurement, or to the group that was guided by 
conventional parameters. In the GDT group, a CI of greater than 3 L/min/m was targeted 
with IVF, inotropes, and blood transfusion starting from CPB and ending eight hours after 
arrival to the ICU. Goal directed therapy using fluids, inotropes, and blood transfusion 
reduced 30-day major complications; lower rate of infection ([12.9% vs 29.7%] p = 
0.002) and low cardiac output syndrome ([6.5% vs 26.6%] p = 0.002). The GDT group 
also had lower cumulative dosage of inotrope ([12 vs 19 mg/kg] p = 0.003) and a shorter 
ICU ([3 vs 5 days] p < 0.001) and hospital length of stay ([9 vs 12 days] p = 0.049). 
There were however, no differences in 30-day mortality (Osawa et al.). 
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Kapoor and colleagues (2017) studied the effect of GDT on patients undergoing 
off-pump CABG surgery. There were 66 patients in the GDT group and 76 patients in 
control group. The GDT arm utilized CI, SVR index, oxygen delivery index, SVV, 
continuous central venous oxygen saturation, global end-diastolic volume, and 
extravascular lung water measurements to guide therapy, in addition to standard 
hemodynamic management that the control arm used. Goal directed therapy was 
continued for 48 hours postoperatively in the ICU. The GDT arm had a significantly (p < 
0.001) shorter length of hospital stay (7.42 ± 1.48) compared to the conventional arm 
(5.61 ± 1.11 days). The GDT group also had a significantly (p < 0.001) shorter length of 
ICU stay (4.2 ± 0.82) compared to the conventional arm (2.53 ± 0.56 days), and 
significantly (p = 0.005) lower duration of inotrope usage (3.24 ± 0.73) compared to the 
conventional arm (2.89 ± 0.68 h). The two groups did not differ in duration of ventilated 
hours, mortality, and other complications.  
As shown here, there are studies in the literature that have found benefits when 
using GDT. However, it is difficult to make definite conclusions, as there is considerable 
variation between studies of the goals of therapy and the hemodynamic parameters and 
the monitoring devices that were utilized. One study had a goal of CI >3 while another 
was >2.5.  Hemodynamic parameters that were considered GDT in one study were 
considered part of the control group in another. Devices used to measure hemodynamic 
parameters also differed between studies. 
Fluid types. The type of fluid that is used also has a significant impact on the 
hemodynamic outcomes in cardiac surgery patients. Colloids and crystalloids are the two 
main types of resuscitation fluids.  
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Crystalloids. Crystalloids include electrolyte containing fluids. Normal saline, 
which is widely used, is increasingly being considered as ‘unbalanced’ because of the 
lack of other essential extracellular ions including potassium, bicarbonate, calcium, 
magnesium, and phosphorous as well as its’ chloride rich content. This is thought to 
induce renal artery vasoconstriction, acute kidney injury and hyperchloremic metabolic 
acidosis (Frazee & Kashani, 2016).  Balanced solutions such as lactated Ringers or 
Plasma-Lyte are considered to be superior choices. However, in the SPLIT trial by Young 
et al. (2015), where they compared the effect of balanced crystalloids to normal saline on 
ICU patients, it was found that the use of balanced crystalloids did not reduce the risk for 
developing acute kidney injury. Reddy et al. (2017) conducted a post hoc subgroup 
analysis on cardiac surgery patients in the ICU who were part of the saline vs. balanced 
crystalloid/Plasma-Lyte SPLIT trial. The subgroup study included 954 patients, of which 
475 patients received Plasma-Lyte, and 479 received saline. One hundred and twenty 
eight of 475 patients (26.9%) in the Plasma-Lyte group received blood or a blood product 
compared to 94 of 479 patients (19.6%) in the saline group (OR: 1.51; 95% CI 
[1.11,2.05]; p = 0.008). This was an unexpected finding, as the researchers had expected 
to find that balanced solutions would reduce blood transfusion requirements as compared 
to saline. 
Colloids. Colloids are high-molecular-weight compounds that provide plasma 
expansion by remaining in the intravascular space and increasing the oncotic pressure. 
They include albumin, starches, dextrans, and gelatins, and are often used as an 
alternative to crystalloid solutions in fluid management (Mitra & Khandelwal, 2009). 
Finfer and colleagues (2010) studied the type of resuscitation fluids used in 391 ICUs 
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across 25 countries. Geographic and regional practices influenced fluid choice rather than 
patient characteristics, but overall colloids were used more often as a resuscitation fluid 
than crystalloids. The data showed 48% of resuscitation episodes being treated with 
colloids as compared to 33% with crystalloids, with the remaining treated with blood 
products.  
Several studies have been conducted in septic, non-cardiac and cardiac surgery 
patients to evaluate the effect of colloids and the results seem to indicate that colloids 
may have fewer benefit, and higher risk. A few of the studies are discussed briefly.  
Navickis, Haynes, and Wilkes (2012) conducted a meta-analysis of RCTs that 
compared the impact of hydroxyethyl starch (HES) to albumin on bleeding after surgery 
using CPB. They included 18 RCTs with 970 patients who received colloids 
perioperatively for volume expansion (nine trials), pump priming (five trials), or both 
(four trials). Compared with albumin, HES significantly (p < .001) increased 
postoperative bleeding by 33.3% of a pooled SD, more than doubled the risk for 
reoperation due to bleeding (RR; 2.24; [p = .020]), and significantly increased the 
transfusion of red blood cells by 28.4% of a pooled SD (p < .001), of fresh frozen plasma 
by 30.6% (p = .008), and of platelets by 29.8% (p = .027).  Albumin was found to 
improve hemodynamics in this meta-analysis. However, there were no differences in 
fluid balance, ventilator time, intensive care unit stay, or mortality (Navickis et al.)  
In a cohort study by Bayer et. al. (2013), of 6478 patients who underwent cardiac 
surgery with CPB, treatment with synthetic colloids including both starch and gelatin was 
associated with a higher risk of renal failure and greater use of renal replacement therapy.  
Gelatin was associated with a higher risk of hospital death (OR: 1.72; 95% CI [1.15, 
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2.58], p = 0.008), than treatment with crystalloid or starch. There was no difference in the 
time to achieve hemodynamic goals or vasopressor cessation among groups. While the 
crystalloid group required more fluid volume initially, by the second day, it was similar to 
the colloid group. These investigators concluded that the use of starches and gelatins had 
less benefit than harm and their use was not advisable unless there was further evidence 
of their safety.    
Frenette et. al. (2014) conducted a retrospective cohort study of patients 
undergoing on-pump cardiac surgery to examine the risk of acute kidney injury (AKI) 
associated with the use colloids. Acute kidney injury was defined by the RIFLE (risk, 
injury, failure, loss and end-stage kidney disease) risk and Acute Kidney Injury Network 
(AKIN) stage 1 serum creatinine criterion within 96 hours after surgery. The cohort 
included 984 patients who either underwent CABG and/or valve replacement surgery. 
Persons with known kidney disease were excluded from the study.  
With respect to colloid administration, 82%, 43% and 16% of individuals received 
HES 6%, pentastarch 10% or albumin, respectively. In the patients who developed AKI, 
and who also received colloids, the greatest risk for AKI was associated with the use of 
albumin (OR: 3.9; 95% CI [ 2.1,6.8]; p < 0.001). Risk was marginal with the use of 
pentastarch 10% (OR: 1.7; 95% CI [1.0 ,3.0]; p = 0.06) and absent with the use of HES 
6%. To address any indication bias, the researchers matched 141 cases who received 
albumin to 141 controls with a similar risk profile, who did not receive albumin and 
developed a propensity score. In this analysis, albumin was associated with an increased 
AKI risk (RIFLE risk: 12% vs. 5%, p = 0.03; AKIN stage 1: 28% vs. 13%, p = 0.002). 
They repeated propensity matching in 50 cases and 50 controls without postoperative 
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hemodynamic instability and still identified a significant association between the use of 
albumin and AKI; AKIN stage 1 AKI (30% vs. 8%, p = 0.005). Consideration should be 
given to the fact that this is a single-center study with limitations inherent to its 
retrospective design (Frennete et al.). 
Summary: Challenges in Fluid Management and Cardiac Surgery 
Fluid management in surgical patients has been a challenging subject, because of 
the difficulty to define or accurately measure volume deficit, predict fluid responsiveness 
and replenish just enough, but not too much fluid. Inadequate replenishment can lead to 
obvious dangers such as shock and organ damage, but also affect recovery by increasing 
issues such as nausea and vomiting, poor wound healing and infection. Fluid overload on 
the other hand can lead to complications related to increased tissue edema, such as of the 
lungs or the abdomen. Getting the balance right is of utmost importance, but difficult to 
achieve. While restricted fluid regimens are increasingly finding favor, the absolute 
amount of fluid that is defined as liberal in one study might be defined as standard in a 
different study, while a standard amount of fluid may be a restrictive amount in another. 
The same problem exists with GDT. The studies are varied and use different devices to 
predict fluid requirements and have different target parameters. The results have also not 
been consistent. On top of these issues, is the one of fluid type: crystalloid vs. colloid; 
colloid vs. colloid (starch, gelatin or albumin); and crystalloid vs. crystalloid (normal 
saline or lactated Ringers solution) debate.  
Cardiac surgeries are different from other surgeries in many ways. They are major 
surgeries, often involving the use of CPB and cardioplegia. Patients may experience 
prolonged hypothermia, more than in other surgeries. Often CPB results in a systemic 
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inflammatory response which causes capillary leak and causes fluid to leave the 
intravascular space into the interstitial space. These, among other factors, increases the 
risk for hemodynamic alterations.  Because of these differences, it is important to study 
the issues of fluid and hemodynamics specific to this specialty. There are several studies 
on various aspects of fluid management in cardiac surgery; however, there is still much 
debate on how best to administer fluids, what hemodynamic indices are the most reliable 
guides, and what type of fluid provides the most benefit and least risk. Fluid management 
in cardiac surgery is a difficult and challenging subject and requires continued 
exploration and examination. 
 Next, the theoretical framework that guided this review will be presented.  
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Theoretical Framework 
The integrative review method is an approach that utilizes research built on 
diverse methodologies to study a problem. Unlike a systematic review that may only use 
RCTs, an integrative review allows the use of experimental, nonexperimental, 
quantitative or qualitative studies to find evidence. Whittemore and Knafl published an 
article in 2005 where they presented an updated and modified integrative review 
framework. This framework purposes to enhance rigor when combining various 
methodologies. It consists of five stages. These stages included; problem identification, 
literature search, data evaluation, data analysis, and presentation. All the stages of this 
framework, except for data evaluation were used. Polit and Beck’s (2016) approach for 
critiquing studies, was the method used for data evaluation. The four stages by 
Whittemore and Knafl (2005), and how they were used for this review are briefly 
described below. 
Problem Identification 
The authors describe the first stage of the integrative review  as the clear 
identification of the problem and the purpose of the review. This is followed by a 
determination of the variables of interest which include the concepts, target population 
and health care problem. Likewise, in this review, the problem was identified and 
articulated clearly. The variables of interest that would be researched were determined. 
Some of these variables included standard fluid management practices, different 
approaches and hemodynamic parameters used in cardiac surgery.  
Literature Search 
  The second stage of the review involves the formulation of a well-defined 
literature search strategy, and includes all relevant literature on the problem. The 
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literature search process should be clearly documented and include the search terms, the 
databases used, additional search strategies, and the inclusion and exclusion criteria for 
selection of  sources. This review utilized these guidelines to formulate a well-defined 
strategy to identify and utilize relevant literature. It clearly documented the search 
strategies in the method section. In keeping with the scope of the integrative review 
method, studies that utilized diverse methodologies were incorporated. They included 
RCTs, observational studies, retrospective and prospective studies and surveys. 
Data Analysis 
 In this stage the data from primary sources is organized, categorized and 
summarized. The evidence is interpreted and synthesized in a thorough and unbiased 
manner. The stages of data analysis included data reduction, data display, data 
comparison and drawing of conclusions and verification. Using these as a guide, the data 
obtained from the selected articles in this review was thoroughly examined, organized 
and cross analyzed. This allowed for conclusions to be made which are presented at the 
end of the paper. 
Presentation 
 The conclusions are reported in a diagrammatic or tabular format. Clear and 
detailed evidence from primary sources are provided to support conclusions. Implications 
for practice are emphasized as well as those for research and policy initiatives. All 
methodological limitations of the review are explicitly stated. Using this as a guide this 
review summarized the evidence obtained and presented conclusions. It also explicitly 
stated the limitations of the review and finally presented recommendations for practice 
and implications for future research. 
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Data Evaluation 
 The data evaluation method by Polit and Beck (2016), was used to critically 
appraise all literature evaluated in this integrative review. This method involves the 
careful evaluation of every aspect of a study article. In keeping with their guidelines, 
every area and section of the research paper was critiqued. Some of these include the 
title, the abstract, the problem statement, and the research methodology. This method is 
further elaborated in the next section of this review.  
 Next, the method will be presented. 
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Method 
Purpose of the Project 
 The purpose of this review was to explore and analyze the current evidence in 
published literature on fluid management in cardiac surgery patients.  
Design 
 The design was an integrative literature review. 
Inclusion Criteria 
 Quantitative studies on fluid management in adult cardiac surgery patients were 
included. In keeping with the integrative review design, there was no restriction on level 
of evidence. Observational studies, cohort studies, and surveys were included, as well as 
RCTs. On pump and off pump procedures were included. Only English language studies 
were included. Relevant data that has been generated within the last 5 years; from 2012 to 
October 2017 were included. 
Exclusion Criteria 
 The articles that were excluded from this review included those which involved 
• Studies on the pediatric population;  
• Non-cardiac surgeries or procedures such as aortic arch replacement which may 
be more of a vascular surgery;  
• Studies that seek to show relationship between two hemodynamic indices rather 
than those that study fluid management on outcomes; 
• Studies that seek to evaluate certain predictors of fluid responsiveness; 
• Qualitative studies; 
• Fluid management that is primarily related to the priming solution used for CPB; 
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• Studies that primarily focus on a population with a specific disease or condition, 
such as renal failure or heart failure; 
• Studies that provided no data on the fluid volumes that were utilized. 
Data Collected 
 A variety of data were collected from the articles that were included in this 
review. While most of the studies yielded information regarding parameters that guided 
fluid management, data on fluid types was obtained from studies on surveys. Patient 
outcome data was obtained from the studies comparing GDT to standard care. The data 
that were collected include the following;  
• Comparison between studies of what was considered as standard or usual care and 
what was the GDT; 
• Hemodynamic parameters that guided fluid management; 
• Outcomes of the therapy on postoperative recovery, such as time to extubation, 
duration of inotrope or vasopressor usage; 
• Complications if available; 
• Length of stay, including ICU and hospital stay; 
• Mortality; 
• Duration of ventilation; 
• Use of inotropes and vasopressors; 
• Review of fluid administration will include the type of fluid and their volumes. 
Assessment Criteria 
 Polit and Beck’s (2016) critical appraisal guidelines were used to assess the 
quality of the study articles. Their quantitative research critique guide was used for this 
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review. Every area and section of the research paper was critiqued. These included the 
title, the abstract, the problem statement, the research question, the literature review and 
the conceptual framework. Critique of the methodology included the research design, the 
population and sample, and the data collection and measurement instruments. Data 
analysis of the findings and a discussion of the interpretation of the results was 
conducted. Finally, the critique reviewed protection of human rights and appropriate 
study participant safeguards, including institutional board review by an external 
organization. General issues such as the presentation of the paper, use of appropriate flow 
charts and clarity of the writing were also considered (Polit &Beck, 2016). 
 Next, the results section will be presented. 
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Results 
After duplicates were removed, 695 articles were found to be suitable for further 
review based on database searching. Of these, 50 abstracts were reviewed after excluding 
articles based on inclusion/exclusion criteria. Further examination led to a full text review 
of 21 articles, of which 13 study articles met inclusion criteria and were included in this 
review (Figure 1). 
 
 
 
 
  
TEE 
 
 
 
   
 
  
  
 
 
  
 
 
     Figure 1. Flow chart depicting search method and results. 
Literature search 
Databases: CINAHL, MEDLINE, PUBMED 
Search Term combinations: 
Cardiac surgery, or heart surgery, or cardiovascular or 
coronary artery bypass or cardiopulmonary bypass 
AND fluid =701 
Cardiac surgery, or heart surgery, or cardiovascular or 
coronary artery bypass or cardiopulmonary bypass 
AND goal directed=52 
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Of the 13 studies identified, four were surveys that  sought to examine practices 
related to cardiac surgery including fluid management. All of these were conducted in 
European countries. There was one observational study that was conducted in order to 
study fluid management practices in ICUs in Australia and New Zealand. Finally, there 
were eight studies that examined the effects of GDT in cardiac surgery patients. The 
results of these studies will be discussed in the next few pages. First, the surveys will be 
briefly discussed. These will be followed by a discussion of the observational study, and 
finally by a discussion of the studies on GDT. 
Studies on Postal and Online Surveys 
Kastrup et al. (2013) conducted a survey of German ICU physicians regarding 
management practices in cardiac surgery (Appendix A, Table A-1). One aspect of this 
survey included questions related to volume monitoring and replacement strategies. The 
authors compared the results of this 2012 survey to a similar survey done in 2005.  The 
investigators found that for monitoring of fluid therapy, there was a significantly 
(p=0.006) increased use of the systolic pressure variation in 2012 (32.6%), compared to 
2005 (14.6%). There was significantly (p=0.027) increased use of the left ventricular end 
diastolic area index with the TEE ; 13.6% in 2012 compared to 8.3% in 2005. There was 
also significantly (p=0.025) increased utilization of extravascular lung water 
measurement with transpulmonary thermodilution; 14.1% in 2012 compared to 8.1% in 
2005. For volume therapy, there was a significant (p=0.007) reduction in the use of HES 
with 38.7% in 2012 compared to 63.4% in 2005, with a corresponding significant 
(p=0.042) increase in the use of crystalloids 41.9% in 2012 compared to 22.4% in 2005 
(Kastrup et al.). 
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Sponholz, Schelenz, Reinhart, Schirmer, and Stehr, (2014) surveyed German 
anesthesia departments involved in cardiac surgery regarding hemodynamic monitoring, 
catecholamine and fluid therapy practices (Appendix A, Table A-2). The investigators 
found that fluid administration was most often based on CVP, TEE and arterial blood 
pressure curve. All these methods had a median value of 2 on a Likert Scale of 1 to 5, 
where 1 is common and 5 is rare. With regard to fluid choices, crystalloids were the fluids 
of first choice during and after surgery (median; 2). 
Bignami et al. (2015) surveyed cardiothoracic ICU’s to determine current 
management practices in cardiac surgery, and included questions on fluid administration 
(Appendix A, Table A-3). The results showed that for monitoring volume status, CVP 
was used most frequently (26.7 %), followed by arterial BP (19.7 %) and 
echocardiography (5.6 %).  The first choice for volume replacement were crystalloid 
solutions in 86.8 %, followed by artificial colloids in 11.8 % of the centers. 
Protsyk et al. (2017) surveyed ICUs in 18 European countries to determine 
current perioperative fluid management practices in cardiac surgery patients (Appendix 
A, Table A-4). The investigators found that balanced crystalloids alone were most 
frequently used for intraoperative management (74%). Crystalloids along with synthetic 
colloids were used 15% of the time and other fluids; alone, or in combination were used 
11% of the time.  The results of this survey were limited by a small survey response rate 
of only 28 %. 
Observational Study on Fluid Administration Practices in Cardiac Surgery 
Parke, McGuiness, Gilder, and McCarthy (2014), conducted an observational, 
multi-center, prospective study  in four ICUs in New Zealand and Australia to obtain data 
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on fluid administration practices in cardiac surgery (Appendix B). The study included 
235 patients. The number of fluid boluses given were 1226, with an average volume of 
504 ml per bolus. The median total IV fluid intake was 4493 ml/patient (interquartile 
range [IQR], 2842–5498 ml), of which the median fluid given for volume expansion in 
the first 24 hours was 2250 ml (IQR, 1250–3500 ml). The decision to administer a fluid 
bolus was made 45% of the time by an ICU resident, 40% by nursing staff, and 12% by 
an ICU specialist. The most common primary indication for fluid administration was 
hypotension (65%), while the most common secondary indication was low CVP (42.9%).  
Nurses were more likely than doctors to administer crystalloid (83.6% v 52.7% of 
boluses) and more likely to cite hypotension (69.9% v 61.3%) or low CVP (16.4% v 7%) 
as the primary indication. Crystalloid fluid was used for 65% of the boluses (Parke et al., 
2014). 
Studies on Goal Directed Therapy in Cardiac Surgery 
Goepfert et al. (2013) conducted a prospective RCT involving CABG and/or 
aortic valve replacement to compare outcomes of a GDT to usual care (Appendix C, 
Table C-1). They randomized 50 patients to the study or GDT group and 50 to the usual 
care group.  Fluid administration in the usual care group was based on CVP. If the CVP 
was less than 8 mm Hg, fluid boluses were administered. If the CVP was greater than 8 
mm Hg, but the MAP remained less than 65 mm Hg, catecholamines were initiated. In 
the GDT group, fluid was administered to the patients until the stroke SVV was less than 
or equal to 10%. If the SVV was less than 10 %, but the CI remained less than 2.0 l/min 
m-2, vasopressors were initiated.  
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The results showed that there was no significant (p=0.221) difference in fluid 
intake between the two groups (mean 11,701 ± SD 2,175 ml in the study group vs. 12,313 
± 3,281 ml in the control group.  While there was no difference in the amount of 
crystalloids utilized, significantly (p < 0.001) more colloid was administered in the study 
group both intraoperatively (mean 1293 ml in the control group vs. 880 ml in the study 
group), as well as in the postoperative ICU period; (mean 1774 ml in the study group vs. 
1237 ml in the control group) (p =0.008).  
In terms of outcomes of the GDT, there was significantly (p = 0.002) reduced 
intraoperative norepinephrine use in the study group mean 9.0 ± SD 7.6 µg/kg  vs. 14.9 ± 
11.1 µg/kg in the control group, significantly (p = 0.004) fewer post-operative 
complications (40 in the study group vs. 63 in the control group), and significantly (p = 
0.001)  shorter time to reach ICU discharge criteria, (15 ± 6 h in the study group vs. 24 ± 
29 h in the control group) and significantly (p = 0.018)  shorter length of ICU stay (42 ± 
19 h in the study group vs. 62 ± 58 h in the control group) (Goepfert et al.). 
Thomson, Meeran, Valencia, and Al-Subaie (2014) conducted a prospective 
observational study to assess the effect of a nurse driven GDT that maximized stroke 
volume for 8 hours postoperatively in cardiac surgery patients (Appendix C, Table C-2). 
This was a single center study conducted in an ICU in the UK. There were 123 patients in 
the GDT group and 141 in the standard therapy group.   
Fluid administration in the standard therapy group was based on perceived 
clinical need, MAP, CVP, lactate level, urine output, and base deficit. The GDT utilized 
CO and SV measurements along with CVP. The intervention started with recording of 
baseline SV, CO, and CVP, followed by the administration of 250 ml of fluid bolus. If 
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this resulted in the SV increasing by 10 % or more, the fluid bolus was repeated until the 
SV no longer increased with fluid boluses by 10 %. If the CVP increased by six points at 
any time, the fluid boluses were stopped. 
The results showed that there was no significant (p = 0.09) difference in the 
volume of intravenous fluid administered in both groups during the first eight hours in the 
ICU (2704 [1393] mL in the usual care group vs. 2905 [1367] mL in the GDT group). 
The incidence of acute kidney was significantly (p = 0.002) decreased in the GDT group: 
6.5% in the GDT group vs. 19.9% in the usual care group. The median duration of 
hospital stay was significantly (p = 0.004) lower in the GDT group, six days compared to 
the usual care group (seven days). There was significantly (p=0.04) reduced incidence of 
ICU readmissions in the GDT group 4(3.3%) compared to the usual care group 13(9.2%) 
(Thomson et al., 2014) 
Fellahi and colleagues (2015) conducted a prospective RCT that compared the 
impact of a GDT on patients undergoing CABG to standard care during the intraoperative 
period (Appendix C, Table C-3). The GDT utilized CO which was measured using a 
special type of endotracheal tube called the endotracheal cardiac output monitor 
(ECOM). There were 44 patients in the control group and 48 in the study group. In the 
control group, the fluid was administered based on the usual hemodynamic parameters 
including BP, CVP, urine output, skin mottling, and arterial pulse pressure variation. In 
the ECOM group a fluid bolus of 100 ml was administered when the SVV was greater 
than 11%, and repeated until correction of SVV to less than 11%. If the CI remained less 
than 2.4 l/min m-2, despite corrected SVV, then dobutamine would be initiated. 
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Significantly (p= 0.042) more patients in the ECOM group received fluid loading 
(n=41) compared to the control group (n=30). However, the total intraoperative amount 
of fluid was significantly (p= 0.035) decreased in the ECOM group (mean 400 ml) when 
compared with the control group (mean 500). The only significant difference in outcome 
between the two groups was the time to extubation which was significantly (p= 0.005) 
decreased by 60 minutes on average in the ECOM group when compared with the control 
group (Fellahi et al.). 
Parke, McGuiness, Gilder, McCarthy, and Cowdrey (2015) conducted a 
prospectively randomized interventional feasibility study to trial using a conservative 
post-operative fluid administration protocol in cardiac surgery (Appendix C, Table C-4). 
They randomized 74 patients to the usual care group and 70 to the intervention group. In 
the intervention group a fluid bolus consisting of 250 to 500 ml was administered if the 
CI was less than 2.5 l/min m-2 and the SVV was greater than 13 %. If these parameters 
were at goal and the patient remained hypotensive with MAP less than 65 mmHg, 
vasoconstrictor medications were initiated. Fluid administration  in the usual care group 
was based on the nurses’ discretion up to a limit of two liters, when they deemed it was 
necessary. MAP and CVP were most commonly used to determine fluid requirement in 
this group.  
The results showed that the intervention group received significantly (p<0.001) 
less fluid bolus (median [IQR] 1620ml [500–3410]) compared to the usual care group 
(median 2520 ml [1440–5250ml]) as well as significantly (p=0.001) lower overall IVF 
volume (median 2050ml [910–4280 ml]) compared with the usual care group (median 
2980ml [2070–6580 ml])  from ICU admission until extubation.  The total amount of 
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fluids administered from admission to 24 hours were also significantly (p=0.02) less in 
the intervention group (median 4350 ml [2790–6160 ml]) than in the usual care group 
(median 5080 ml [3930–7320 ml]). There was no significant difference in any outcomes 
between the two groups. (Parke et al.). 
Walker and Young (2015) studied the effect of a postoperative GDT in high-risk 
cardiac surgery (Appendix C, Table C-5). This study was a single-center, interventional 
pilot study conducted in a hospital in New Zealand. It compared a prospective cohort of 
40 high-risk cardiac surgical patients with a retrospective cohort of 40 patients. The 
prospective cohort received the intervention, while the retrospective cohort had received 
usual care. The intervention involved the administration of fluids, and vasoactive 
medications to target a CI greater than 2 l/min/m2, a mixed venous oxygen saturation 
greater than 60%, and a MAP of 65 to 75 mmHg, for the first 12 hours of surgery. 
The results showed that there was no significant difference in the duration of 
vasopressor infusion between the two groups. The intervention group received 
significantly (p <0.001) more fluid (4687±2284) in the first 12 hours postoperatively than 
the usual care cohort (1189±1344 ml). The intervention group also had a significantly 
(p=0.049) higher rate of reintubation (4 in 37 [10.8%]) vs. the usual care group (0 in 40 
[0%]) (Walker & Young). 
Shreshta, Pradhan, and Koirala (2015) conducted a prospective RCT on a small 
sample of cardiac surgery patients in Nepal to study the impact of early GDT on 
postoperative outcomes (Appendix C, Table C-6). They randomized  20 CABG and valve 
repair/replacement patients to the study/GDT group and 15 to the control group. 
Hemodynamic parameters for both groups included CVP (6 -10 mmHg), MAP (60 -90 
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mm Hg), and urine output greater than 1 ml/kg/hr. Additional monitoring parameters for 
the GDT group included CI, SVV, stroke volume index (SVI), SVR, ScVO2 and blood 
lactate level. The intervention involved the administration of 100 ml fluid boluses for CI 
less than 2.2 l/min/m2, and if the CVP less than 6 mmHg or the SVV was greater than 
10%. The duration of the intervention was from the opening of sternum until eight hours 
post-surgery. 
The results showed that the study group received more total fluid than the control 
group, although the difference did not reach statistical significance (1199.04 ± 638.701 in 
the GDT group vs. 938.32 ± 736.151 in the control group). There was a significant 
(p=0.041) reduction in ventilator time in the study group ([M] 10.48 ± [S.D] 7.640 hours) 
compared to the control group (16.429 ± 11.801hours).  The duration of inotrope usage 
was also significantly (p=0.032) lower in the study group (23.2 ± 17.870 hours) than the 
control group (39.12 ± 18.615 hours). There was no difference in mortality, rate of 
complications or length of stay between the two groups (Shreshta et al.). 
Osawa and colleagues (2016) conducted an RCT to study the effect of GDT on 
outcomes in high risk cardiac surgery (Appendix C, Table C-7). They randomized 62 
high risk patients undergoing CABG or aortic valve repair to a GDT group and 64 to the 
usual care group. Usual care interventions were guided by heart rate, ScVo2 >70 %, 
lactate level<3, urine output > 0.5 ml/kg/hr and MAP >/ 65.  In the GDT group, CI of 
greater than 3 L/min/m was targeted with IVF, inotropes, and blood transfusion starting 
from CPB and ending eight hours after arrival to the ICU.  
In first eight hours following ICU admission, the median volume of fluid bolus 
administered differed significantly (p < 0.001) between groups (1,000 mL [IQR, 625–
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1500] in the GDT group vs. 500 mL [IQR, 500–1000] in the usual care group. The total 
amount of fluid administered was greater in the GDT group (median [IQR] 1056 ml 
(257–1568 ml) than in the control group (894ml (229–1595 ml)  but this did not reach 
significance (p=0.85). In terms of outcomes, the GDT group had significantly (p=0.002) 
lower rate of infection (12.9%) compared to the usual care group (29.7%), and 
significantly (p=0.003) reduced incidence of low cardiac output syndrome (6.5% in the 
GDT group vs. 26.6% in the usual care group). The GDT group also had significantly (p 
= 0.003) lower cumulative dosage of inotrope (12 in GDT group vs. 19 mg/kg in the 
usual care group), and a significantly (p = 0.049) shorter ICU (3 days in the GDT group 
vs. 5 days in the usual care group) and hospital length of stay ([9 days in the GDT group 
vs. 12 days in the usual care group] p = 0.049). There were however, no differences in 
30-day mortality (Osawa et al.).  
Kapoor et al. (2016) studied the effect of GDT on patients undergoing off-pump 
CABG (Appendix C, Table C-8).  They randomized 66 patients to the GDT group and 76 
patients to the control group. In the control group, therapy was guided by CVP, MAP, end 
tidal CO2 (EtCO2), temperature, arterial blood gas analysis, hematocrit and urine output. 
In the GDT group, in addition to these measures, CI, SVV, continuous central venous 
oxygen saturation and ELVI measurements were utilized. The intervention consisted of 
the administration of 100 ml fluid bolus if the CI was less than 2.2 l/min/m2, the CVP  
was less than 6 mmHg or the SVV was greater than 10%. This was repeated until these 
goals were achieved. Goal directed therapy was continued for 48 hours post-operatively 
in the ICU.  
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The results showed that the extra fluid administered was significantly (p=0.003) 
more in the GDT group (376.33 ± 55.23 ml) than the control group (343.33 ± 62.02 ml). 
In terms of outcomes, the GDT arm had a significantly (p < 0.001) shorter length of 
hospital stay (7.42 ± 1.48 days) compared to the conventional arm (5.61 ± 1.11 days). 
The GDT group also had a significantly (p < 0.001) shorter length of ICU stay (4.2 ± 
0.82) compared to the conventional arm (2.53 ± 0.56 days), and significantly (p = 0.005) 
lower duration of inotrope usage (3.24 ± 0.73 hours) compared to the conventional arm 
(2.89 ± 0.68 hours). The two groups did not differ in duration of ventilated hours, 
mortality, and other complications (Kapoor et al.). 
Cross Analysis of Studies 
In this section, the cross analysis findings of the four surveys on practices in 
cardiac surgery and the eight studies on GDT in cardiac surgery will be presented. One 
study by Parke et al. (2014) is not categorized under either of these headings and has 
already been discussed in the previous section. The cross analysis of the surveys will be 
presented first followed by that of the GDT studies. 
Postal and online surveys. The postal and online surveys that are included in this 
review (Bignami et al., 2015; Kastrup et al., 2013; Protsyk et al., 2017; Sponholz et al., 
2014) were all conducted in European countries between 2012 and 2017 (Appendix D, 
Table D-1). All surveys except for the study conducted by Protsyk and colleagues (2017) 
sought to obtain knowledge about basic and advanced hemodynamic monitoring 
techniques, volume replacement strategies, and the use of vasopressor or inotropic drugs 
utilized in cardiac surgery. Protsyk and colleagues’ survey design  addressed only the 
fluid types used in cardiac surgery.  
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The survey research done by Sponholz et al. and Bignami et al. found that CVP 
and ABP were most often used often to monitor volume status along with 
echocardiography. Additionally, Kastrup et al. discovered that there was increased use of 
TEE, systolic pressure variation and extravascular lung water monitoring in the centers 
surveyed  (Appendix D, Table D-2). All the survey results (Bignami et al., 2015; Kastrup 
et al., 2013; Protsyk et al., 2017; Sponholz et al., 2014) found that crystalloids were the 
fluid of first choice for volume replacement (Appendix D, Table D-2).  While the survey 
by Kastrup and colleagues (2013) found that there was a reduction in the use of HES 
compared to a previous survey in 2005 (Appendix D, Table D-2), HES was still popular 
and was the fluid of second choice for volume replacement (Bignami et al., 2015; 
Kastrup et al., 2013; Sponholz et al. 2014)The latest survey by Protsyk and colleagues 
(2017), however,  found that when colloids were used, gelatin was more popular than 
HES or albumin (Appendix D, Table D-2). 
Goal directed therapy in cardiac surgery. Eight studies based on GDT in 
cardiac surgery have been included in this review (Appendix E, Table E-1). All eight 
studies sought to determine the most appropriate manner of fluid administration by 
targeting preset goals. One of them by Parke and colleagues (2015), had the specific aim 
to reduce IV fluid administration.  
Five of the studies were RCTs, one was a prospective observational study 
(Thomson et al., 2014) one was a prospective randomized feasibility study (Parke et al., 
2015), and one was a prospective study in which the intervention group was compared to 
a retrospective cohort (Walker & Young, 2015). All the studies except the one by Kapoor 
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et al. (2016) were conducted in single centers. Kapoor and colleagues conducted their 
study in two centers. 
Two of the studies evaluated GDT during the intra-operative period; (Fellahi et 
al., 2015; Goepfert et al., 2013), three evaluated GDT during the postoperative period 
(Parke et al., 2015; Thomson et.al, 2014; Walker & Young, 2015), and the last three 
evaluated the effects of GDT in the intraoperative as well as postoperative phase of 
surgery (Kapoor et al., 2016; Osawa et al., 2016; Shreshta et al., 2015) The studies were 
all conducted with CABG or/and valve surgery patients, with three studies specifically 
conducted with high risk patients (Kapoor et al., 2016; Osawa et al., 2016; Walker & 
Young, 2015). 
All the studies provided data on the hemodynamic goals for fluid therapy and 
administration of vasoactive medications in the GDT group (Appendix E, Table E-2). All 
authors except Walker & Young (2016), also provided data about the standard monitoring 
methods or interventions in the usual care group. The usual care group in most of the 
studies included treatment based on CVP, MAP or ABP and urine output. In the study by 
Goepfert et al. (2013), fluid boluses were administered in the usual care group if the CVP 
was less than 8 mm Hg. However, if the CVP was greater than 8 mm Hg, and the MAP 
remained less than 65 mm Hg, catecholamines were initiated. In the study by Parke et al. 
(2015), nurses were allowed to administer up to two liters of crystalloid fluid based on 
their own clinical judgment of hemodynamic inadequacy, MAP, and CVP measurements. 
In the study conducted by Thomson and colleagues (2014), the patients in the usual care 
received IV fluids based on the perception of clinical need, which was guided by arterial 
and venous pressures, serum lactate concentrations, urine output, and base deficit. 
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The GDT interventions included algorithms that involved fluid administration 
based on SVV and CI.  Many studies had a goal for SVV less than or equal to 10 % and 
fluid was administered until this goal was achieved (Goepert et al., 2013; Kapoor et al., 
2016; Shrestha et al., 2015; Thomson et al., 2014); however, two of the studies had a 
higher limit to treat the SVV (Fellahi et al., 2015 [SVV 11 %]; Parke, et al., 2015 [SVV 
13 %]). Target goal for CI in most studies were between 2.0 and 2.5 l/min/m2. The study 
by Osawa and colleagues (2016) had a higher target of CI 3.0 l/min/m2. and fluid or 
vasopressor/inotropes were administered to achieve these targets. In addition to CI and 
SVV, MAP goals were provided by many of the studies and had targets of 65 mm Hg or 
greater (Parke et al., 2015; Kapoor et al., 2016; Walker & Young, 2015). Fluid bolus 
volumes  ranged from 100 ml to 500 ml, given repeatedly until targets were achieved. 
The studies by Shrestha et al. (2015) and Kapoor et al. (2016) also utilized CVP 
measurements in the GDT arm of their studies and fluid was administered for CVP less 
than 6 mm Hg.   
Data on the amount of fluids used was reported in all the studies (Appendix E, 
Table E-3); however, comparison of fluid amounts administered was somewhat difficult 
because the data provided by different studies varied with regard to the timing of 
administration. Despite this, a slight trend toward more fluid being administered in the 
GDT groups compared to the usual care groups is discernible. The exception was the 
study by Parke et al. (2015), where the investigators were studying a conservative fluid 
approach and administered less fluid. Walker & Young’s (2016) study was remarkable in 
that the GDT group received almost four times more fluid and had poorer outcomes when 
compared to the control group. In the study by Goepfert et al. (2013), the GDT group 
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received more colloid than the control group. In the study by Fellahi et al., even though 
more fluid boluses were administered, the total intraoperative fluid amount was actually 
less than the control group. 
In terms of outcomes, the length of hospital stay or time to discharge was reported 
in all the studies except for the one by Walker and Young. A trend toward a decreased 
length of hospital stay in studies using GDT is discernible from the cross analysis table 
(Appendix F, Table F-1). The length of ICU stay has been reported in all the studies 
(Appendix F, Table F-2). Four of the eight studies (Goepfert et al., 2013;  Kapoor et 
al.,2016; Osawa et al.,2016; Thomson et al., 2014.) reported a significant decrease in 
length of ICU stay in the GDT groups. 
Mortality data has been reported in six of the eight studies (Appendix F, Table F-
3).  Parke et al. reported one death in the control group, while Goepfert et al. did not 
report any deaths or mortality data. The data in the cross analysis table indicates that 
there is no discernible effect of GDT on mortality.  
Complications have been reported in all studies except the one by Kapoor 
(Appendix F, Table F-4). Significantly fewer complications were reported in the studies 
done by Goepfert et al., Osawa et al., and Thomson et al. The study by Thomson et al. 
looked only at renal complications. Osawa et al. found a significant decrease in infections 
and low cardiac output syndrome. Walker & Young’s (2015) study findings, on the other 
hand, showed a significant increase in reintubations in the GDT group. Overall there is no 
discernable trend towards a decrease in complications from the use of GDT. 
Time to extubation has been reported in all the studies (Appendix F, Table F-5), 
except in the one by Thomson et al. Three studies had significantly decreased time to 
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extubation in the GDT group (Fellahi et al., 2015; Kapoor et al., 2016; Shrestha et al., 
2015) while Walker & Young’s study had increased time to extubation in the GDT group. 
Observation of the cross analysis table does not clearly indicate a trend towards 
decreased time to extubation. 
All the studies in this review except for those by Thomson et al. (2014) and Parke 
et al.(2015) reported the use of vasopressors and/or inotropes (Appendix F, Table F-6). 
Two studies reported significantly less dose and duration of vasopressors and inotropes 
(Goepfert et al., 2013; Osawa et al., 2016), while two studies reported decreased duration 
of inotrope use (Kapoor et al., 2016; Shrestha et al., 2015). The studies by Fellahi et al. 
and Walker & Young, reported increased use of inotropes and vasopressors in the GDT 
group. Overall, no trend can be discerned from observation of the data. 
Next, the summary and conclusions will be presented. 
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Summary and Conclusions 
Fluid management is an essential element in cardiac surgery. It is critical that 
fluids are administered appropriately in order to avoid the dangers of hypovolemia as 
well as fluid overload. Fluid management in surgery is a complex field with varying 
evidence regarding best approaches to administration, types of fluids to use, and the most 
appropriate parameters in assessment. While there is a considerable amount of literature 
on this subject in non-cardiac surgery, evidence on best practices pertaining to cardiac 
surgery is not as well defined or established. The purpose of this integrative review was 
to research the current evidence that is available regarding fluid management in cardiac 
surgery.  
The updated and modified integrative review framework by Whittemore and 
Knafl (2005) was used to guide this review. An extensive review of literature which 
incorporated fluid balance concepts, hemodynamic monitoring and parameters that guide 
fluid resuscitation, fluid management approaches in adult cardiac and non-cardiac 
surgeries, and different types of fluids used in perioperative fluid management was 
included in the review. This was done in order to help the reader understand the current 
issues and practices in the field of fluid management.  
This was followed by a search for studies that demonstrated what the usual or 
standard practices related to fluid management in the cardiac surgery population were, as 
well as any studies that sought to compare different approaches to fluid administration.  
Only two studies, both by Parke et al. (2014 & 2015), were found that exclusively studied 
fluid administration in cardiac surgery. Four surveys on practices in cardiac surgery, all of 
them conducted in Europe, were identified, and the fluid management aspects of the 
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surveys were used for this review. Additional information regarding fluid management in 
cardiac surgery was obtained by examining studies on GDT in cardiac surgery. While the 
focus of these studies was not exclusively fluid management, fluid administration was an 
important part of the therapies administered.  
The critical analysis method by Polit and Beck (2016) was utilized to critically 
appraise the quality of the studies. The quality of all the studies was found to be adequate 
and allowed them to be included in this review. The studies were carefully reviewed and 
then cross-analyzed. 
Cross-study analysis of the results found that in cardiac surgery, CVP and ABP 
were most often used often to monitor volume status along with echocardiography. It is 
important to note that CVP has not been shown to be a good predictor of fluid status. 
Other measures used included the urine output, serum lactate concentrations, urine 
output, and base deficit. The study by Kastrup et al. (2013) showed that in terms of 
volume monitoring there was increased used of TEE, systolic pressure variation, and 
extravascular lung water monitoring in the centers surveyed.  
In terms of fluid choice, the European studies found that crystalloids were the first 
fluid of choice for volume replacement. In addition, while HES was still commonly used, 
in general, its’ used had decreased. The most recent survey by Protsyk et al. (2017) 
showed that when colloids were used, gelatin was more often used than HES.  
The studies that used GDT in cardiac surgery most often used algorithms that 
involved fluid administration based on SVV and CI. Several of the studies had a goal for 
SVV less than or equal to 10 % and fluid was administered until this goal was achieved. 
Cardiac index targets for most studies were between 2.0 and 2.5 l/min/m2. When fluid 
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boluses were administered, the volumes often ranged from 100 ml to 500 ml, given 
repeatedly, until targets were achieved.  
With regard to fluid volumes used, there was a slight trend toward an increased 
amount of fluid administered in the GDT groups as compared to the usual care groups. 
The exception was the study by Parke et al. (2015), where the investigators trialed a 
conservative fluid approach and found that administering smaller volumes of fluid based 
on targeted goals did not result in negative outcomes. This was highlighted by research 
such as that conducted by Walker and Young (2015). They found that when almost four 
times more fluid was administered in a GDT group, it resulted in increased incidence of 
reintubation. Overall, however, it is difficult to make any definite conclusion about fluid 
amounts because the fluid data reported in the studies varied in terms of timing of 
administration. 
This review showed that there is evidence supporting a slight trend toward 
decreased length of stay in the hospital as well as a discernible decrease in ICU in the 
GDT groups. There was no decrease in mortality between the GDT and the usual care 
groups in any of the studies. With regard to the use of inotropes and vasopressors, three 
studies showed a decrease in the duration/dose of inotropes and vasopressors, but it is 
difficult to make any conclusion because the data reported varied with regard to the agent 
used, timing of administration and question asked. In respect to number/incidence of 
complications, three of the eight studies resulted in a decrease in number of  
complications in the GDT group compared to the usual care group, but an overall trend 
toward decreased incidence of complications could not be concluded. Likewise, while 
three studies resulted in decreased time to extubation, a trend toward reduced duration of 
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mechanical ventilation could not be concluded. In the study by Walker and Young, 
(2015), the GDT group had significantly higher incidence of reintubation. This was 
attributed by the authors to the protocol design which lead to the delivery of almost four 
times more fluid in the GDT group than the usual care group. The protocol involved  
repeatedly administering fluid as long as there was a rise of CI >10% in response to a 
fluid bolus. This was also the only study which compared a prospective cohort to a 
matched retrospective cohort. While discussing limitations of the study, the investigators 
suggested that the time separation between the two groups could have allowed for 
changes in staffing and changes in practice that arose with the passage of time.  
There are several limitations to this review. The studies are a mix of RCTs, 
surveys, and observational studies. Articles used in this study were not all peer reviewed. 
These include the surveys by Protsyk et al. (2017) and Sponholz et al. (2014), as well as 
the two studies by Parke et al. (2014 & 2015) and the study by Shreshta et al. (2016). 
However, these publications were used in this review to maximize the amount of 
evidence that could be obtained. There were no studies found that were conducted in 
North America, which is noteworthy because this review is being conducted in the United 
States of America, and it is important to obtain data on practices in this country. Without 
a good understanding of what the current practices are, it is difficult to apply any findings 
or make recommendations. Other limitations included the fact that the GDT interventions 
varied in terms of timing, methods, type of devices, and risk profile of patients, which 
may have had an impact on the outcomes. The cross-analysis of the studies was based on 
observation, without the use of any statistical method to analyze the results. There were a 
limited number of articles that dealt purely with the question of fluid administration, and 
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the two articles that studied it were both by the same investigator (Parke et al., 2014 & 
2015). 
In conclusion, fluid management in cardiac surgery is an important and 
challenging aspect of cardiac surgical practice. It is essential to administer fluid that is 
adequate to prevent hypovolemia and hypoperfusion but it is also important to temper 
this with caution and be vigilant to avoid over administration of fluid. Much more study 
is required to ascertain best practices for volume monitoring and fluid administration. 
Research in North America on what parameters practitioners use to administer fluid, what 
type of fluids are most often used, what devices or methods are used to monitor fluid 
status and their effects on outcomes, may help to increase our understanding of this 
complex area of practice. 
Next, the recommendations and implications for advanced nursing practice will 
be presented. 
 
 
 
 
 
 
 
 
 
 
 
      59 
Recommendations and Implications for Advanced Nursing Practice 
Nurses have a major role in the care of the patient undergoing cardiac surgery. 
The ICU staff nurse receiving the patient out of the OR must be skilled in assessing and 
managing the patient in the immediate postoperative phase when there is high risk for 
complications and deterioration. The nurse juggles multiple tasks that include but are not 
limited to receiving a thorough hand off report from the anesthesia provider, assessment 
and management of hemodynamic values, hypothermia, laboratory results, mechanical 
ventilation, titration of  vasopressors or inotropes, and alerting the provider about 
complications. An important skill that is part of this gamut of tasks is fluid management.  
The APRN in the role of the nurse anesthetist, who is managing the intraoperative 
care of the patient, is often the one who makes decisions on whether to use advanced 
monitoring devices such as a PAC to measure CI/CO or devices that measure indices 
such as SVV.  Often these decisions are made based on the risk profile of the patient and 
specific comorbidities. These advanced devices can help to monitor and manage fluid 
management with more precision. It is therefore recommended that a goal-directed 
approach be used, especially when managing high risk patients. 
The APRN in the role of the NP is often the one who manages the pre- and post-
operative care of the patient. This involves placing orders for fluids which may include 
crystalloids and/or colloids. Alternately, they may have to place a hold on fluids in favor 
of vasoactive and inotropic medication or blood products. A thorough understanding of 
fluid management concepts, perils of fluid under and over resuscitation, and best fluid 
choices is necessary to optimize care, prevent complications, and improve outcomes. 
 Based on this review, the APRN can make some practice recommendations to 
guide fluid management practices in cardiac surgery. Some of these recommendations 
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may include orders to administer fluid as small boluses when there is suspicion of 
hypovolemia. Suspicion of hypovolemia  might be based on MAP, or if advanced 
monitoring is available, on the CO/CI, or SVV.  A bolus of 250 ml to 500 ml of fluid 
should be administered. If the patient responds to the bolus with improvement of MAP 
and CO/CI or with a decrease in SVV, they are fluid responders and these boluses may be 
repeated until they stop responding to the bolus. The recommendations could also include 
advice to avoid administering large fluid boluses as liter bags without stopping to see if 
the patient is responding to the fluid. This is important not only because of the danger of 
fluid overload, but also because hypotension or decreased CO can often be caused by 
factors other than hypovolemia. These factors include decreased cardiac contractility or 
vasodilatation in the immediate postoperative period. These conditions may require 
inotropes or vasopressors instead of fluid and it is important to use these agents 
appropriately in the correct context. If there is any doubt as to how best to manage the 
patient’s hemodynamic values, the staff nurse should seek clarification from the surgeon 
or the APRN managing care of the patient. 
 Advanced practice nurses in all roles, including in the role of the CNS, are in  a 
pivotal position to provide education and mentoring of staff nurses regarding the issues of 
fluid management. Examples of educational topics may include the perils of 
hypervolemia/fluid overload or administration of fluid based on fluid responsiveness. If a 
GDT protocol is instituted in the APRN’s work site, the APRN should educate, train and 
evaluate the knowledge of the nurses who will implement it.  
 The APRN, in collaboration with the surgeons, staff nurses, and anesthetists can 
lead efforts to create fluid administration policies or protocols. An example of this could 
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be a policy that prevents the staff nurse from administering more than two liters of fluid 
without first alerting the provider in the immediate postoperative period. The APRN can 
also lead quality and safety initiatives related to fluid management practices. This could 
take the form of chart audits to review fluid administration data, patient outcomes such as 
the duration of ventilation, complications, and length of stay. It could also involve the 
development of educational initiatives for staff and other providers and assessing the 
results of these of initiatives on fluid practices and patient outcomes.  
 Fluid management in cardiac surgery is a difficult and challenging subject and 
requires continued exploration and examination. There is much debate on how best to 
administer fluids, what hemodynamic indices are the most reliable guides, and what type 
of fluid provides the most benefit and least risk. The APRN can further this body of 
knowledge by initiating or participating in research initiatives. Some ideas for research 
could include an investigation of the current postoperative fluid management practices in 
cardiac surgery in the APRN’s work area,  
 exploration of clinical decision making in prescribing and administering fluids, 
retrospective chart review of fluid balance and postoperative outcomes, comparing a new 
GDT protocol to usual care, and comparing the outcomes of crystalloid bolus infusions to 
colloid bolus infusions.  
 In all these ways, the APRN in the role of the nurse anesthetist, CNS, and the NP 
can make valuable contributions to the field of fluid management in cardiac surgery and 
improve patient outcomes. 
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Appendix A 
Critical Appraisal of Studies Featuring Postal surveys 
Table A-1 
 Kastrup et al., 2013. Clinical impact of the publication of S3 guidelines for intensive care in cardiac surgery patients in Germany: 
results from a postal survey. 
 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title conveyed the content and premise 
of the study and the population, which 
involved a postal survey conducted to assess 
clinical practice in cardiac surgery patients. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, 
results, conclusions)? 
The abstract did not clearly articulate the 
intent of the study. Other components 
including the method, results and conclusion 
were clear and concise. 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Did the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used? 
The researchers stated the problem clearly 
and provided a good reason to conduct a 
new study. They used a quantitative 
approach to conduct the research, which was 
appropriate for the nature of the study. 
Hypotheses or 
research questions 
 
• Was the research hypotheses explicitly stated? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and 
the study population?  
The study described the results of a postal 
survey conducted to evaluate current clinical 
practices surrounding cardiac surgery. There 
was no hypothesis or research question. 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
The study had a brief literature review that 
introduced available evidence, and used 
mainly primary sources.  
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• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
Conceptual/theoretical 
framework 
• Were key concepts adequately defined?   
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is 
the absence of a framework justified? 
The study did not identify a conceptual 
framework. 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? Was the study 
externally reviewed by an IRB/ethics review board? 
There was no documentation of ethics 
review or participant safeguards. This may 
not be applicable, owing to the nature of the 
study. 
Research design • Was the most rigorous design used, given the study 
purpose? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study 
(e.g., was blinding used, was attrition minimized)? 
A survey was sent to ICU physicians from 
an address database by two German medical 
societies of cardiothoracic surgery and 
anesthesiology, collected by them, and then 
returned to the authors of the study.  
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the sample size based on a power analysis? 
The survey targeted ICU physicians who 
provided care for cardiac surgery patients. 
No details on type of surgery or patient 
characteristics were provided. 
Data collection and 
measurement 
 
 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described  
A survey comprising 37 questions covering 
four major areas that included the different 
basic and advanced hemodynamic 
monitoring techniques, volume replacement 
strategies, and use of vasopressor or 
inotropic drugs in different clinical 
situations was sent out to ICU physicians, 
which were filled and returned 
anonymously. 
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Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there 
evidence of intervention fidelity? 
 
The questionnaire itself was provided in the 
appendix. Of the surveys sent out, 77.5% 
were returned completed. 
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
• Were appropriate statistical methods used? 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
Appropriate statistical methods were used to 
analyze the data. Tests used included  
Mann–Whitney U-test and the chi-square 
tests. 
Findings • Was information about statistical significance 
presented?  Was information about effect size and 
precision of estimates (confidence intervals) 
presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates 
meta-analysis with sufficient information needed for 
EBP? 
P value less than 0.05 was considered 
significant. Findings were presented with 
information about statistical significance. 
Results showed that compared to previous 
survey in 2005, there was increased use of 
systolic pressure variation (32.6% [2012] 
compared to 14.6% [2005]{p=0.006}), TEE 
(13.6% [2012] compared to 8.3% 
[2005]{p=0.027}), and extravascular lung 
water (14.1% [2012] compared to 8.1% 
[2005]{p=0.007}) for volume monitoring. 
There was increased use of crystalloids 
(41.9% [2012] compared to 22.4% 
[2005]{p=0.007}) and decreased use of 
HES (38.7% [2012] compared to 63.4% 
[2005]{p=0.006}). 
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Results were presented with good use of 
graphs and tables.  
 
Interpretation of the 
findings 
• Were findings interpreted and discussed within the 
context of prior research?  
• Were the issue of clinical significance  discussed? 
•  Did the report address  generalizability of the 
findings? 
The findings were discussed within context 
of previous research, and the clinical 
significance of the study was discussed.  
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and 
were those implications reasonable and complete? 
The researchers discussed the implications 
of the study in clinical practice, as well as 
for further research.  
 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the 
study? 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was not used. 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
Study was published in an academic journal, 
and has been peer reviewed.  
Summary assessment • Despite any limitations, do the study findings appear 
to be valid 
The study findings do appear to be valid. 
Note. TEE= transesophageal echocardiography; HES=hydroxyethyl starch. 
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Table A-2 
 Sponholz et al., 2014. Catecholamine and volume therapy for cardiac surgery in Germany--results from a postal survey. 
 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting 
key variables and the study population? 
The title conveyed the content  and premise 
of the study and the population. It was a 
study of a postal survey on volume and 
catecholamine therapy in cardiac surgery. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, 
results, conclusions)? 
The abstract clearly and concisely outlined 
the main features of the study. 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Did the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used? 
The researchers stated the problem clearly 
and provided a good reason to conduct a 
new study. They used a quantitative 
approach to conduct the research, which 
was appropriate for the nature of the study. 
Hypotheses or 
research questions 
 
• Was the research hypotheses explicitly stated? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and 
the study population?  
No hypothesis was stated. The aim of the 
study was to present the results of a postal 
survey evaluating current intraoperative 
hemodynamic monitoring, catecholamine 
and volume therapy practices at German 
cardiothoracic centers. 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
 Literature review was limited. The problem 
was introduced using mainly primary 
sources.   
Conceptual/theoretical 
framework 
• Were key concepts adequately defined?   The study did not identify a conceptual 
framework. 
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• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is 
the absence of a framework justified? 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? Was the study externally 
reviewed by an IRB/ethics review board? 
Ethics Committee approval was obtained.  
Informed consent requirement was waived 
because of the anonymous nature of the 
study. 
Research design • Was the most rigorous design used, given the study 
purpose? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study 
(e.g., was blinding used, was attrition minimized)? 
The research design was a postal survey. 
This was an appropriate design for the 
purpose of the study. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the sample size based on a power analysis? 
The survey was sent to department heads of 
81 centers performing cardiac surgery. The 
study provided adequate detail such as the 
number and type of surgery. 
Data collection and 
measurement 
 
 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described  
The method was described adequately. The 
23 item survey that was mailed included 
areas pertaining to hemodynamic 
monitoring practices and volume 
replacement strategies, as well as other 
areas such as catecholamine usage in 
cardiac surgery. 
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there 
evidence of intervention fidelity? 
 
The survey itself was provided in the 
appendix. Of the questionnaires that were 
returned, and after excluding those from 
centers that also included pediatric surgery, 
50 questionnaires were included in the 
study. 
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Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
• Were appropriate statistical methods used? 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
Categorical data depicted by frequencies 
and values were graded on Likert scales. 
Analysis included percentages with median, 
mean, minimum and maximum values with 
95% CI. 
Findings • Was information about statistical significance 
presented?  Was information about effect size and 
precision of estimates (confidence intervals) 
presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates 
meta-analysis with sufficient information needed for 
EBP? 
Results showed that on a 1 to 5 categorical 
Likert scale with 1 being the most common 
and 5 being rare, volume monitoring most 
commonly utilized undulating arterial 
pressure curve (median 2), CVP (median 2) 
and TEE (median 2). Crystalloids were the 
fluids of first choice during and after 
surgery (median 2). 
The data was presented and summarized 
well with good use of graphs and tables. 
 
Interpretation of the 
findings 
• Were findings interpreted and discussed within the 
context of prior research?  
• Were the issue of clinical significance  discussed? 
•  Did the report address  generalizability of the 
findings? 
The findings were discussed within context 
of previous research, and the clinical 
significance of the study was discussed.  
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and 
were those implications reasonable and complete? 
The researchers discussed the implications 
of the study in clinical practice, as well as 
for further research.  
 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the 
study? 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was not used. 
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Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
Study was published in an academic journal, 
but  has not been peer reviewed.  
Summary assessment • Despite any limitations, do the study findings appear 
to be valid 
The study findings do appear to be valid. 
Note. TEE= transesophageal echocardiography; CVP=central venous pressure; CI=confidence interval 
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Table A-3 
Bignami et al., 2015. Clinical practice in perioperative monitoring in adult cardiac surgery: is there a standard of care? Results from 
an national survey. 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title conveyed the content  and premise 
of the study and the population. It was a 
survey of the standards of care and clinical 
practice in cardiac surgery. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, 
results, conclusions)? 
The abstract clearly and concisely outlined 
the main features of the study. 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Did the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used? 
The researchers stated the problem clearly 
and provided a good reason to conduct a 
new study. They used a quantitative 
approach to conduct the research, which was 
appropriate for the nature of the study. 
Hypotheses or 
research questions 
 
• Was the research hypotheses explicitly stated? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and 
the study population?  
No hypothesis was stated. The aim of the 
survey was to investigate current clinical 
practice, hemodynamic monitoring and the 
use of inotropic drugs after cardiac surgery 
in Italy. 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
The authors conducted a brief review of 
literature that introduces the problem and 
the evidence that is available, using mainly 
primary sources. 
Conceptual/theoretical 
framework 
• Were key concepts adequately defined?   
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is 
the absence of a framework justified? 
The authors did not identify a conceptual 
framework. 
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Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? Was the study 
externally reviewed by an IRB/ethics review board? 
The authors stated that no data regarding 
individual patients was collected and that 
research was carried out in compliance with 
the Helsinki Declaration. There was no 
mention of an IRB or ethics board review. 
Research design • Was the most rigorous design used, given the study 
purpose? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study 
(e.g., was blinding used, was attrition minimized)? 
The research design was a postal survey. 
This was an appropriate design for the 
purpose of the study. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the sample size based on a power analysis? 
The survey was sent to 92 Centers 
performing adult cardiac surgery. The 
researchers provided details about the 
numbers and type of cardiac surgery. 
Data collection and 
measurement 
 
 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described  
The method was described adequately. A 
survey comprising 33 questions covering 
both intra- and postoperative issues were 
emailed to anesthesiologists in 
cardiothoracic ICUs, which after completion 
was emailed or faxed back to the 
researchers. 
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there 
evidence of intervention fidelity? 
 
The survey itself was provided in the 
appendix. The researchers were able to 
include 77.2%  of the returned surveys in 
their analyses after excluding those that 
involved pediatric patients. 
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
• Were appropriate statistical methods used? 
Results were presented as percentages, 
which was appropriate for the nature of the 
study. 
      86 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
Findings • Was information about statistical significance 
presented?  Was information about effect size and 
precision of estimates (confidence intervals) 
presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates 
meta-analysis with sufficient information needed for 
EBP? 
The data was presented in a narrative with 
percentages, as well as with graphs in the 
form of bar charts which are summarized 
well. 
The results showed that for monitoring 
volume status, CVP was used most 
frequently (26.7 %), followed by ABP (19.7 
%) and echocardiography (5.6 %).  The first 
choice for volume replacement were 
crystalloid solutions in 86.8 %, followed by 
artificial colloids in 11.8 % of the centers 
 
Interpretation of the 
findings 
• Were findings interpreted and discussed within the 
context of prior research?  
• Were the issue of clinical significance  discussed? 
•  Did the report address  generalizability of the 
findings? 
The findings were discussed within context 
of previous research, and the clinical 
significance of the study was discussed.  
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and 
were those implications reasonable and complete? 
The researchers discussed the implications 
of the study in clinical practice, as well as 
for further research.  
 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the 
study? 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was not used. 
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Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
This study was published in an academic 
journal, and has been peer reviewed.  
Summary assessment • Despite any limitations, do the study findings appear 
to be valid 
The study findings appear to be valid. 
Note. CVP=central venous pressure; ABP=arterial blood pressure. 
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Table A-4 
Protsyk et al., 2017.  Fluid Management in Cardiac Surgery: Results of a Survey in European Cardiac Anesthesia Departments. 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title conveyed the content  and premise 
of the study and the population. It was a 
postal survey of  fluid management in 
cardiac surgery in European cardiac 
anesthesia departments. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, 
results, conclusions)? 
The abstract clearly and concisely outlined 
the main features of the study. 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Did the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used? 
The researchers stated the problem clearly 
and provided a good reason to conduct a 
new study. They used a quantitative 
approach to conduct the research, which 
was appropriate for the nature of the study. 
Hypotheses or 
research questions 
 
• Was the research hypotheses explicitly stated? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and 
the study population?  
No hypothesis was stated. The aim of the 
study was to evaluate current fluid 
management practices in cardiac surgery in 
Europe. 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
 Literature review was limited. The problem 
was introduced using mainly primary 
sources.   
Conceptual/theoretical 
framework 
• Were key concepts adequately defined?   
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is 
the absence of a framework justified? 
The study did not identify a conceptual 
framework. 
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Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? Was the study 
externally reviewed by an IRB/ethics review board? 
Ethics Committee approval was obtained.   
Research design • Was the most rigorous design used, given the study 
purpose? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study 
(e.g., was blinding used, was attrition minimized)? 
The research design was an online survey. 
This was an appropriate design for the 
purpose of the study. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the sample size based on a power analysis? 
The survey questionnaire was sent to 379 
cardiac surgery anesthesiologists in 18 
European countries.   
The study provided adequate detail such as 
the number and type of surgery. 
Data collection and 
measurement 
 
 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described  
The method was described adequately. The 
26 item online questionnaire included areas 
related to perioperative fluid therapy 
practices in cardiac surgery patients. Most 
of the questions evaluated the type of fluid 
used and reasons for selecting them. 
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there 
evidence of intervention fidelity? 
 
The questionnaire itself was provided in the 
appendix.  
The response rate was only 28%, with 106 
returned questionnaires, of which 5 were 
incomplete. 
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
• Were appropriate statistical methods used? 
• Were type I and Type II errors avoided or 
minimized? 
Results given as amounts and percentages. 
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• In intervention studies, was an intention-to-treat 
analysis performed? 
Findings • Was information about statistical significance 
presented?  Was information about effect size and 
precision of estimates (confidence intervals) 
presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates 
meta-analysis with sufficient information needed for 
EBP? 
The investigators found that balanced 
crystalloids alone were most frequently used 
for intraoperative management (74%). 
Crystalloids along with synthetic colloids 
were used 15% of the time and other fluids; 
alone, or in combination were used 11% of 
the time. 
The data was presented and summarized 
well with good use of graphs and tables. 
 
Interpretation of the 
findings 
• Were findings interpreted and discussed within the 
context of prior research?  
• Were the issue of clinical significance  discussed? 
•  Did the report address  generalizability of the 
findings? 
The findings were discussed within context 
of previous research, and the clinical 
significance of the study was discussed.  
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and 
were those implications reasonable and complete? 
The researchers discussed the implications 
of the study in clinical practice, but not for 
future research.  
 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the 
study? 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was not used. 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
Study was published in an academic journal, 
but  has not been peer reviewed.  
Summary assessment • Despite any limitations, do the study findings appear 
to be valid 
The response rate for the online survey was 
very low, therefore the results may not be 
generalizable. 
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Appendix B 
Study On Fluid Use in Cardiac Surgery 
Parke, 2014. Intravenous fluid use after cardiac surgery: a multicenter, prospective, observational study. 
Aspect of the 
Report 
Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title identified the intent of the study 
and the population. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, results, 
conclusions)? 
The abstract outlined all the components of 
the study clearly and concisely 
Introduction 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Is the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used –that is, was a quantitative 
approach appropriate? 
The researchers stated the problem clearly 
and provided a good reason to conduct this 
study. They used a quantitative method to 
study this problem, which is appropriate for 
the nature of the study. 
Hypotheses or 
research questions 
• Were research questions and/or hypotheses 
explicitly stated?  If not, was their absence justified? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and the 
study population? 
• Were the questions/hypotheses consistent with 
existing knowledge? 
No hypothesis was stated. The aim of the 
study was to evaluate the current practice of 
fluid administration to patients after cardiac 
surgery. 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
There was a brief literature review based on 
current and primary sources that was used to 
introduce the problem. 
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• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
• Did the literature review provide a strong basis for 
the new study? 
Conceptual/theoretical 
framework 
• Were key concepts adequately defined conceptually? 
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is the 
absence of a framework justified? 
• Were the questions/hypotheses consistent with the 
framework? 
The study did not identify a conceptual 
framework. 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? 
• Was the study externally reviewed by an IRB/ethics 
review board? 
• Was the study designed to minimize risks and 
maximize benefits to participants? 
The researchers mentioned that the 
requirement for informed consent was 
waived by the ethics committees in the four 
countries where the study was conducted.  
Research design • Was the most rigorous design used, given the study 
purpose? 
• Were appropriate comparisons made to enhance 
interpretability of the findings? 
• Was the number of data collection points 
appropriate? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study (e.g., 
was blinding used, was attrition minimized)? 
This was a prospective observational study 
and was an appropriate design for the intent 
of the study. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the best possible sampling design used to 
enhance the sample’s representativeness?  Were sampling 
biases minimized? 
The population was identified as adult 
patients admitted to the ICU after cardiac 
surgery. Details of type of surgery and basic 
demographic characteristics were provided. 
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• Was the sample size based on a power analysis? Two hundred and thirty five patients 
participated in the study. 
Data collection and 
measurement 
 
 
 
• Were the operational and conceptual definitions 
congruent? 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described and 
were they good choices, given the study population and the 
variables being studied? 
• Did the report provide evidence that the data 
collection methods yielded data that were reliable, valid and 
responsive? 
Demographic data was collected by trained 
research staff at each site using a 
standardized data collection form.  
A data dictionary with definitions and 
descriptions for all data points was provided 
to each site. The data was collected 
prospectively by the person administering 
the fluid. 
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there evidence 
of intervention fidelity? 
• Were data collected in a manner that minimized 
bias?  Were the staff who collected data appropriately 
trained? 
Observational study. No intervention was 
administered. 
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
• Were appropriate statistical methods used, given the 
level of measurement of the variables, number of groups 
being compared, and assumptions of the texts? 
• Was a powerful analytic method used?  (e.g., did the 
analysis help to control for confounding variables)? 
• Were type I and Type II errors avoided or 
minimized? 
Data was presented as means with SDs and  
medians with interquartile ranges. Kruskal–
Wallis test was used to test differences 
between sites. 
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• In intervention studies, was an intention-to-treat 
analysis performed? 
• Were problems of missing values evaluated and 
adequately addressed? 
•  
Findings • Was information about statistical significance 
presented?  Was information about effect size and precision 
of estimates (confidence intervals) presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates a 
meta-analysis, and with sufficient information needed for 
EBP? 
The researchers found that postoperatively, 
cardiac surgical patients receive 4–5L of 
fluid input in the first 24 hours, of which 
almost 50% is from fluid boluses prescribed 
by nursing or junior medical staff for the 
indication of hypotension. 
The findings were summarized well and 
tables and figures were added. 
 
Discussion 
Interpretation of the 
findings 
• Were all major findings interpreted and discussed 
within the context of prior research and/or the study’s 
conceptual framework? 
• Were casual inferences, if any, justified? 
• Was the issue of clinical significance discussed? 
• Were interpretations well-founded and consistent 
with the study’s limitations? 
• Did the report address the issue of the 
generalizability of the findings? 
The findings were discussed within context 
of previous research, and the clinical 
significance of the study was discussed. 
The issue of generalizability was discussed. 
The researchers stated that because the 
study only observed a convenience sample 
in a small number of sites, the results may 
not be universally applicable. 
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and were 
those implications reasonable and complete? 
The researchers discussed the implications 
of the study in clinical practice, as well as 
for further research. They stated their 
intention to conduct an RCT to assess the 
efficacy of a goal-directed strategy aimed at 
reducing fluid administration in patients 
after cardiac surgery. 
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General Issues 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the study? 
• Was the report written in a manner that makes the 
findings accessible to practicing nurses? 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was not used. 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
Study was published in an academic journal, 
but has not been peer reviewed. The 
researchers are ICU specialists and nurses 
with research training. 
Summary assessment • Despite any limitations, do the study findings appear 
to be valid—do you have confidence in the truth value of 
the results? 
• Does the study contribute any meaningful evidence 
that can be used in nursing practice or that is useful to the 
nursing discipline? 
The study findings  appear to be valid 
despite its limitations. 
 
Note. SD=standard deviation, RCT=randomized controlled trial. 
 
 
 
 
 
 
      96 
Appendix C 
Studies on Goal Directed Therapy in Cardiac Surgery 
Table C-1 
Goepfert et al., 2013. Individually optimized hemodynamic therapy reduces complications and length of stay in the intensive care unit: 
a prospective, randomized controlled trial. 
Aspect of the 
Report 
Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title clearly identified the key variables 
but did not identify the population. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, results, 
conclusions)? 
The abstract outlined all the components of 
the study clearly and concisely. 
Introduction 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Is the problem statement build a persuasive argument 
for the new study? 
• Was there a good match between the research 
problem and the methods used –that is, was a quantitative 
approach appropriate? 
The researchers stated the problem clearly 
and provided a good reason to conduct a 
new study. They used a quantitative method 
to study this problem, which was 
appropriate for the nature of the study. 
Hypotheses or 
research questions 
• Were research questions and/or hypotheses explicitly 
stated?  If not, was their absence justified? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and the 
study population? 
• Were the questions/hypotheses consistent with 
existing knowledge? 
The hypothesis was clearly stated and 
appropriately worded.  It asked the 
question; “Does a goal-directed 
hemodynamic therapy, based on the 
combination of functional and volumetric 
hemodynamic parameters, improve 
outcomes in patients with cardiac surgery”. 
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Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
• Did the literature review provide a strong basis for 
the new study? 
The study had a brief literature review 
based on current and primary sources that 
was used to introduce the problem. 
Conceptual/theoretical 
framework 
• Were key concepts adequately defined conceptually? 
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is the 
absence of a framework justified? 
• Were the questions/hypotheses consistent with the 
framework? 
No conceptual framework was articulated. 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? 
• Was the study externally reviewed by an IRB/ethics 
review board? 
• Was the study designed to minimize risks and 
maximize benefits to participants? 
Approval was obtained from the 
government ethics committee prior to the 
study. Informed consent was obtained from 
all patients. 
Research design • Was the most rigorous design used, given the study 
purpose? 
• Were appropriate comparisons made to enhance 
interpretability of the findings? 
• Was the number of data collection points 
appropriate? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study (e.g., 
was blinding used, was attrition minimized)? 
Yes. This was a single-site, prospective, 
controlled, randomized, parallel-arm, open 
label trial. While blinding of the caregiving 
physicians was impossible, outcomes were 
assessed by independent researchers in 
order to reduce potential bias. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
The population was described in sufficient 
detail and consisted of patients undergoing 
CABG, AVR, or combined CABG and 
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• Was the best possible sampling design used to 
enhance the sample’s representativeness?  Were sampling 
biases minimized? 
• Was the sample size based on a power analysis? 
AVR surgeries under CPB. There were 50 
patients in the study/GDT group and 50 in 
the control group. The sample size was 
determined by power analysis. 
Data collection and 
measurement 
 
 
 
• Were the operational and conceptual definitions 
congruent? 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described and 
were they good choices, given the study population and the 
variables being studied? 
• Did the report provide evidence that the data 
collection methods yielded data that were reliable, valid and 
responsive? 
The study did not provide detail on how the 
data was collected or measured. It was 
presumed that this was done through 
monitoring devices, medical records, and 
via direct observation. 
The primary outcome was fitness to be 
discharged from the ICU. Secondary 
outcomes included post-operative 
complications and the need for vasopressor 
support.  
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there evidence 
of intervention fidelity? 
• Were data collected in a manner that minimized 
bias?  Were the staff who collected data appropriately 
trained? 
The intervention was described well and 
seemed well designed. The intervention 
included administering fluid until SVV< 
/10% or optimal global end diastolic 
volume index was reached unless ELWI>12 
in which case fluid was stopped. If 
SVV<10, but CI > 2.0, then vasopressors, 
atropine, red blood cells or pacing was 
administered as appropriate.  
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
• Were appropriate statistical methods used, given the 
level of measurement of the variables, number of groups 
being compared, and assumptions of the texts? 
Detailed analysis of outcome variables was 
conducted. Appropriate statistical methods 
were used. Data was presented as mean, SD 
and median. 
Tests used: t-test, Mann Whitney rank sum 
test, Fisher exact test, Poisson Regression. 
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• Was a powerful analytic method used?  (e.g., did the 
analysis help to control for confounding variables)? 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
• Were problems of missing values evaluated and 
adequately addressed? 
Measures to minimize type I and II errors 
were taken. P value less than 0.025 was 
considered significant. 
 Intention-to-treat analysis was performed. 
Findings • Was information about statistical significance 
presented?  Was information about effect size and precision 
of estimates (confidence intervals) presented? 
• Were the findings adequately summarized, with good 
use of tables and figures? 
• Were findings reported in a manner that facilitates a 
meta-analysis, and with sufficient information needed for 
EBP? 
Findings were presented with information 
about statistical significance. The authors 
found that in the GDT group there was 
significantly reduced intraoperative 
norepinephrine use (9.0 ± SD 7.6 µg/kg  vs. 
14.9 ± 11.1 µg/kg in the control group [p = 
0.002]), incidence of complications(40 in 
the study group vs. 63 in the control 
group[p=0.004]), time to reach ICU 
discharge criteria (15 ± 6 h in the study 
group vs. 24 ± 29 h in the control group 
[p=0.001]) and length of ICU stay (42 ± 19 
h in the study group vs. 62 ± 58 h in the 
control group [p=0.018]). There was no 
difference in the amount of fluid intake 
between the group, however more colloids 
were administered in the study group. 
The findings were summarized well and 
tables and figures were added. The findings 
were presented in a manner that facilitates 
future meta-analysis. 
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Discussion 
Interpretation of the 
findings 
• Were all major findings interpreted and discussed 
within the context of prior research and/or the study’s 
conceptual framework? 
• Were casual inferences, if any, justified? 
• Was the issue of clinical significance discussed? 
• Were interpretations well-founded and consistent 
with the study’s limitations? 
• Did the report address the issue of generalizability ? 
The findings were discussed within context 
of previous research, and the clinical 
significance of the study was discussed. 
The researchers suggested that early 
implementation of therapy with appropriate 
goals improves outcomes. 
The report did not mention the issue of 
generalizability of findings. 
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and were 
those implications reasonable and complete? 
Implications for clinical practice and further 
research were discussed. The researchers 
stated that large multicenter trials  are 
required to further prove the utility of these 
methods in daily clinical practice. 
General Issues 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the study? 
 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was not used. 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
Study was published in an academic 
journal, and has been peer reviewed. The 
researchers include professors, and senior 
anesthesiology ICU physicians. 
Summary assessment • Despite any limitations, do the study findings appear 
to be valid—do you have confidence in the truth value of the 
results? 
• Does the study contribute any meaningful evidence 
that can be used in nursing practice or that is useful to the 
nursing discipline? 
The study findings do appear to be valid 
despite its limitations. 
Note. CABG= coronary artery bypass graft; AVR= aortic valve replacement; CPB= cardiopulmonary bypass; GDT= goal directed 
therapy; SVV=stroke volume variation; ELWI=extravascular lung water index; CI=cardiac index; SD=standard deviation 
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Table C-2 
Thomson et al., 2014 Goal-directed therapy after cardiac surgery and the incidence of acute kidney injury. 
 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title clearly identified the key variables 
and the population. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, results, 
conclusions)? 
The abstract outlined all the components of 
the study clearly and concisely 
Introduction 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Is the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used –that is, was a quantitative 
approach appropriate? 
The researchers stated the problem clearly. 
They stated that a significant number of 
patients develop AKI with subsequent 
increased mortality after cardiac surgery. 
GDT to maximize CI has improved 
outcomes in noncardiac surgery. The 
researchers intended to study the safety and 
outcomes of a GDT in cardiac surgery 
patients in their facility. 
Hypotheses or 
research questions 
• Were research questions and/or hypotheses 
explicitly stated?  If not, was their absence justified? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and the 
study population? 
• Were the questions/hypotheses consistent with 
existing knowledge? 
They researchers stated their aim, which 
was to evaluate assess the safety of a 
recently introduced GDT in patients after 
cardiac surgery and its impact on renal 
dysfunction. They implied that GDT can 
improve outcomes in their discussion. 
However, they did not state a hypothesis. 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
The article had a brief literature review and 
mainly used primary sources in the 
introduction of the problem. 
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• Did the literature review provide a strong basis for 
the new study? 
Conceptual/theoretical 
framework 
• Were key concepts adequately defined conceptually? 
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is the 
absence of a framework justified? 
• Were the questions/hypotheses consistent with the 
framework? 
No conceptual framework was articulated. 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? 
• Was the study externally reviewed by an IRB/ethics 
review board? 
• Was the study designed to minimize risks and 
maximize benefits to participants? 
This work was part of a clinical evaluation 
of GDT in the cardiac surgery setting with 
the aim to improve fluid administration on 
the ICU. Therefore, formal ethical approval 
and informed consent were not required in 
accordance with the UK National Health 
Service research authority 
Research design • Was the most rigorous design used, given the study 
purpose? 
• Were appropriate comparisons made to enhance 
interpretability of the findings? 
• Was the number of data collection points 
appropriate? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study (e.g., 
was blinding used, was attrition minimized)? 
This was a prospective, single-center, 
observational study, and was suitable for the 
purpose of clinical evaluation, however by 
virtue of its design it lacked rigor, and had 
limited validity. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the best possible sampling design used to 
enhance the sample’s representativeness?  Were sampling 
biases minimized? 
• Was the sample size based on a power analysis? 
Adult patients undergoing on- and off-pump 
CABG, AVR, or combined CABG and 
AVR admitted to the ICU after surgery were 
included. Additional patient characteristics 
were presented in a table and provided 
sufficient detail. No power analysis was 
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done. Patients who received the GDT were 
considered to be the study group. Other 
patients who did not receive the GDT 
because of the lack of persons trained to 
administer it, were considered to be the 
usual care/control group. 
Data collection and 
measurement 
 
 
 
• Were the operational and conceptual definitions 
congruent? 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described and 
were they good choices, given the study population and the 
variables being studied? 
• Did the report provide evidence that the data 
collection methods yielded data that were reliable, valid and 
responsive? 
The primary outcome measure was AKI, 
and the secondary outcomes were total 
fluids administered in the first 8 
postoperative hours, need for renal 
replacement therapy, duration of hospital 
and ICU stay, and ICU readmission 
No detail about data collection was 
provided, other than it was collected 
prospectively. Data was presumed to have 
been obtained from specific monitoring 
devices that were used and from the medical 
records. 
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there evidence 
of intervention fidelity? 
• Were data collected in a manner that minimized 
bias?  Were the staff who collected data appropriately 
trained? 
The intervention was described in detail and 
adequately in the study. There were 123 
patients in the study group, of which, 20 
patients were excluded from the analysis 
due to interruption of, or incomplete GDT. 
The intervention involved recording 
baseline SV, CO, CVP, then administering 
250 ml fluid bolus. If SV increased by 
>/10 % the bolus would be repeated. 
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
Appropriate statistical methods were used to 
analyze variables.  
Continuous data were presented as mean, 
SD or median IQR. Categorical data were 
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• Were appropriate statistical methods used, given the 
level of measurement of the variables, number of groups 
being compared, and assumptions of the texts? 
• Was a powerful analytic method used?  (e.g., did the 
analysis help to control for confounding variables)? 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
• Were problems of missing values evaluated and 
adequately addressed? 
•  
presented as ratios and percentages. 
Statistical significance was determined by 
using 2-tailed Student t test, Mann-Whitney 
U and Fisher exact tests. 
P value less than 0.05 was considered 
significant. 
Measures to minimize type I and II errors 
were not addressed. 
 Intention-to-treat analysis was not 
performed. 
Findings • Was information about statistical significance 
presented?  Was information about effect size and precision 
of estimates (confidence intervals) presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates a 
meta-analysis, and with sufficient information needed for 
EBP? 
Findings were presented with information 
about statistical significance. The results 
showed that there was no significant 
difference in the volume of intravenous fluid 
administered in both groups during the first 
8 hours in the ICU The incidence of acute 
kidney was significantly decreased in the 
GDT group (6.5% in the GDT group vs. 
19.9% in the usual care group [p=0.02]). 
The median duration of hospital stay was 
lower in the GDT group (6 days in the GDT 
group vs. 7 days in the usual care group 
[p=0.02]). There was significantly reduced 
incidence of ICU readmissions in the GDT 
group compared to the usual care group 
(4[3.3%] in the GDT group vs. 13[9.2%] in 
the control group {p=0.04}). 
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There was good use of tables. Data may not 
be useful for future meta-analyses as this 
was an observational study. 
Discussion 
Interpretation of the 
findings 
• Were all major findings interpreted and discussed 
within the context of prior research and/or the study’s 
conceptual framework? 
• Were casual inferences, if any, justified? 
• Was the issue of clinical significance discussed? 
• Were interpretations well-founded and consistent 
with the study’s limitations? 
• Did the report address the issue of the 
generalizability of the findings? 
The findings were discussed within context 
of previous research, and the clinical 
significance of the study was discussed. 
The report did not address the issue of 
generalizability of the findings. 
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and were 
those implications reasonable and complete? 
The researchers suggested that  a nurse 
delivered GDT which maximized stroke 
volume in the first 8 hours after cardiac 
surgery improved outcomes. 
 They suggested that these findings could be 
a basis for conducting an RCT in this group 
of patients. 
General Issues 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the study? 
• Was the report written in a manner that makes the 
findings accessible to practicing nurses? 
The report was written and organized well 
and allowed for critical analysis. 
 
 
CONSORT flow chart was not used. 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
Study was published in an academic journal, 
and has been peer reviewed. The researchers 
are MDs who work in cardiothoracic ICUs. 
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Summary assessment • Despite any limitations, do the study findings appear 
to be valid—do you have confidence in the truth value of 
the results? 
• Does the study contribute any meaningful evidence 
that can be used in nursing practice or that is useful to the 
nursing discipline? 
The study findings do appear to be valid 
despite its limitations. 
Note. CABG= coronary artery bypass graft; AVR= aortic valve replacement; CPB= cardiopulmonary bypass; GDT= goal directed 
therapy; AKI=acute kidney injury; CVP=central venous pressure; SV=stroke volume; CO= cardiac output; SD=standard deviation; 
IQR=interquartile range 
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Table C-3 
Fellahi et al., 2015. Early goal-directed therapy based on endotracheal bioimpedance cardiography: a prospective, randomized 
controlled study in coronary surgery. 
 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title identified some variables and the 
population. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, results, 
conclusions)? 
The abstract outlined all the components of 
the study clearly and concisely 
Introduction 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Is the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used –that is, was a quantitative 
approach appropriate? 
The researchers stated the problem clearly 
and provided a good reason to conduct a 
new study. They used a quantitative method 
to study this problem, which was 
appropriate for the nature of the study. 
Hypotheses or 
research questions 
• Were research questions and/or hypotheses 
explicitly stated?  If not, was their absence justified? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and the 
study population? 
• Were the questions/hypotheses consistent with 
existing knowledge? 
The hypothesis was clearly stated and 
appropriately worded and suggested that 
GDT using an endotracheal cardiac output 
monitor (ECOM) would improve 
intraoperative hemodynamics, result in less 
postoperative complications and earlier 
hospital discharge in patients undergoing 
CABG. 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
The article had a brief literature review that 
was used to introduce the problem and was 
based on mainly primary sources. 
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• Did the literature review provide a strong basis for 
the new study? 
Conceptual/theoretical 
framework 
• Were key concepts adequately defined conceptually? 
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is the 
absence of a framework justified? 
• Were the questions/hypotheses consistent with the 
framework? 
The study did not identify a conceptual 
framework. 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? 
• Was the study externally reviewed by an IRB/ethics 
review board? 
• Was the study designed to minimize risks and 
maximize benefits to participants? 
Institutional approval was obtained from the 
Ethical committee prior to the study. 
Informed consent was obtained from all 
participants.  
Research design • Was the most rigorous design used, given the study 
purpose? 
• Were appropriate comparisons made to enhance 
interpretability of the findings? 
• Was the number of data collection points 
appropriate? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study (e.g., 
was blinding used, was attrition minimized)? 
 This was a single-site, prospective, 
controlled, randomized, parallel-arm trial. 
While  it was not possible to blind the 
investigators to patient assignment because 
of the use of the ECOM device, an 
independent investigator blinded to the 
patient group assignment assessed  the 
predefined postoperative complications and 
endpoints for all patients. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the best possible sampling design used to 
enhance the sample’s representativeness?  Were sampling 
biases minimized? 
• Was the sample size based on a power analysis? 
The population was described in sufficient 
detail and consisted of patients undergoing 
CABG, with CPB. One hundred consecutive 
patients were randomly allocated to the 
GDT/ECOM group or the control group. 
The sample size was based on power 
analysis. 
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Data collection and 
measurement 
 
 
 
• Were the operational and conceptual definitions 
congruent? 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described and 
were they good choices, given the study population and the 
variables being studied? 
• Did the report provide evidence that the data 
collection methods yielded data that were reliable, valid and 
responsive? 
The study did not provide detail on how the 
data was collected or measured. It was 
presumed that this was done through 
monitoring devices, medical records, and 
via direct observation.  
The primary outcome was fitness to be 
discharged from the ICU. Secondary 
outcomes were true hospital discharge, the 
time to reach extubation, the length of stay 
in ICU, the number of major adverse cardiac 
events, and in-hospital mortality. 
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there evidence 
of intervention fidelity? 
• Were data collected in a manner that minimized 
bias?  Were the staff who collected data appropriately 
trained? 
The intervention was described well and 
seemed well designed. It consisted of the 
administration of 100 ml fluid bolus for 
SVV> 11. After correcting SVV to <11, if 
the CI remained <2.4 dobutamine was 
initiated. 
Two patients in the study group had a 
change in surgical procedure and were 
excluded from analysis and 5 of the 48 
ECOM group patients did not receive the 
intervention because of unavailability of the 
device. They were kept in the ECOM group 
for intention-to- treat analysis, but switched 
to the control group for analysis. 
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
Detailed analysis of outcome variables was  
conducted. Appropriate statistical methods 
were used. Mean ± SD or median used for 
non-normally distributed variables. Between 
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• Were appropriate statistical methods used, given the 
level of measurement of the variables, number of groups 
being compared, and assumptions of the texts? 
• Was a powerful analytic method used?  (e.g., did the 
analysis help to control for confounding variables)? 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
• Were problems of missing values evaluated and 
adequately addressed? 
group comparisons were done using t test, 
Mann–Whitney test, Fisher’s exact test or 
Chi squared test as appropriate. Intention-to-
treat analysis was performed. 
Findings • Was information about statistical significance 
presented?  Was information about effect size and precision 
of estimates (confidence intervals) presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates a 
meta-analysis, and with sufficient information needed for 
EBP? 
P value less than <0.05 was considered 
significant. Hazard ratios were given with 
their 95 % CI. Findings were presented with 
information about statistical significance.  
The results showed that more patients in the 
study group received fluid loading (41) than 
in the control group (30), however the total 
intraoperative fluid  amount was lower in 
the study group (400 ml in the study group 
vs. 500 ml in the control group [p=0.042]). 
The results also showed that there was 
decreased time to extubation in the GDT 
group by an average of 60 minutes 
(p=0.005). 
The findings were summarized well and 
tables and figures were added. The findings 
were presented in a manner that may 
facilitate future meta-analysis. 
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Discussion 
Interpretation of the 
findings 
• Were all major findings interpreted and discussed 
within the context of prior research and/or the study’s 
conceptual framework? 
• Were casual inferences, if any, justified? 
• Was the issue of clinical significance discussed? 
• Were interpretations well-founded and consistent 
with the study’s limitations? 
• Did the report address the issue of the 
generalizability of the findings? 
The findings were discussed within context 
of previous research, and the clinical 
significance of the study was discussed. 
 
 
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and were 
those implications reasonable and complete? 
The researchers discussed the implications 
of the study in clinical practice, as well as 
for further research. They recommended 
large scale studies using ECOM in high-risk 
patients undergoing cardiac and noncardiac 
surgery to further determine its utility in 
improving outcomes. 
General Issues 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the study? 
• Was the report written in a manner that makes the 
findings accessible to practicing nurses? 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was used. 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
Study was published in an academic journal, 
and has been peer reviewed. The researchers 
are MDs in anesthesia, critical care and 
cardiothoracic departments. 
Summary assessment • Despite any limitations, do the study findings appear 
to be valid—do you have confidence in the truth value of 
the results? 
The study findings appear to be valid 
despite its limitations. 
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• Does the study contribute any meaningful evidence 
that can be used in nursing practice or that is useful to the 
nursing discipline? 
Note. CABG= coronary artery bypass graft; CPB= cardiopulmonary bypass; GDT= goal directed therapy; SVV=stroke volume 
variation; CI= cardiac index; SD=standard deviation. 
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Table C-4 
Parke et al., 2015. A Randomised feasibility study to assess a novel strategy to rationalise fluid in patients after cardiac surgery. 
 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title did not clearly indicate the key 
variables or intervention, but included the 
study population. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, results, 
conclusions)? 
The abstract outlined all the components of 
the study clearly and concisely. 
Introduction 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Is the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used –that is, was a quantitative 
approach appropriate? 
The problem was stated clearly and 
provided a good argument for a new study. 
A quantitative approach was used which is 
appropriate for the nature of the study. 
 
 
Hypotheses or 
research questions 
• Were research questions and/or hypotheses 
explicitly stated?  If not, was their absence justified? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and the 
study population? 
• Were the questions/hypotheses consistent with 
existing knowledge? 
The hypothesis was clearly stated and 
specified the key variables involved in the 
study. It questioned whether a stroke 
volume variation-based algorithm could 
reduce the amount of IVF fluid administered 
to patients, after cardiac surgery, and if a 
reduced fluid strategy was safe and 
practical? 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
The literature review was a brief 
introduction to the problem, and used 
mainly primary sources. It did not provide a 
state-of-the-art synthesis of evidence of the 
problem. 
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• Did the literature review provide a strong basis for 
the new study? 
Conceptual/theoretical 
framework 
• Were key concepts adequately defined conceptually? 
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is the 
absence of a framework justified? 
• Were the questions/hypotheses consistent with the 
framework? 
No conceptual framework was articulated. 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? 
• Was the study externally reviewed by an IRB/ethics 
review board? 
• Was the study designed to minimize risks and 
maximize benefits to participants? 
The study was approved by the Regional 
Ethics Committee. Written informed 
consent was obtained by research staff from 
all study participants, before enrolment. 
Research design • Was the most rigorous design used, given the study 
purpose? 
• Were appropriate comparisons made to enhance 
interpretability of the findings? 
• Was the number of data collection points 
appropriate? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study (e.g., 
was blinding used, was attrition minimized)? 
A prospectively randomized study design 
was used. 
Blinding was not feasible. It was a single 
center study, using specific hemodynamic 
instruments, therefore, generalizability was 
limited. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the best possible sampling design used to 
enhance the sample’s representativeness?  Were sampling 
biases minimized? 
• Was the sample size based on a power analysis? 
Population was identified and described in 
detail. It consisted of  patients 16 years or 
older undergoing cardiac surgery, with CPB, 
where 74 were allocated to usual care and 
70 to intervention group. The sample size 
was calculated based on power analysis. 
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Data collection and 
measurement 
 
 
 
• Were the operational and conceptual definitions 
congruent? 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described and 
were they good choices, given the study population and the 
variables being studied? 
• Did the report provide evidence that the data 
collection methods yielded data that were reliable, valid and 
responsive? 
The variables were measured by ICU and 
research nurses at the bedside, as well as 
downloaded from hemodynamic monitors. 
Data collection method was adequately 
described. 
 
The main outcome was a comparison of  the 
amount of fluid used between the two 
groups. The secondary outcome was the 
incidence of AKI. 
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there evidence 
of intervention fidelity? 
• Were data collected in a manner that minimized 
bias?  Were the staff who collected data appropriately 
trained? 
 The intervention was described adequately. 
It consisted of fluid bolus (250- 500 ml) 
administered for CI < 2.5 and SVV>13.  
All patients who were randomized to the 
study group received the intervention, and 
none were lost to follow up. 
Research nurses were involved in data 
collection. 
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
• Were appropriate statistical methods used, given the 
level of measurement of the variables, number of groups 
being compared, and assumptions of the texts? 
• Was a powerful analytic method used?  (e.g., did the 
analysis help to control for confounding variables)? 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
 
All the aspects determined by the hypothesis 
were tested.  
Continuous data was tested for normality 
using histograms. Between-group 
comparisons for continuous data was 
performed by means of Student’s t test or 
the Mann-Whitney U test and categorical 
data with the use of the χ2 test. 
P value <0.05 was considered statistically 
significance. 
Data were analyzed according to the 
intention-to-treat principle. 
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Findings • Was information about statistical significance 
presented?  Was information about effect size and precision 
of estimates (confidence intervals) presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates a 
meta-analysis, and with sufficient information needed for 
EBP? 
Data was presented with information about 
statistical significance, however there was 
no data on effect size or precision estimates.  
The results showed that the GDT group 
received significantly less fluid bolus 
(median [IQR] 1620ml [500–3410]) 
compared to the usual care group (2520 ml 
[1440–5250ml] {p<0.001}) as well as 
significantly lower overall IVF volume 
(2050ml [910–4280 ml]) compared to the 
usual care group (2980ml [2070–6580 ml] 
{p=0.001}) from ICU admission until 
extubation.  The total amount of fluids 
administered from admission to 24 hours 
were also significantly less in the GDT 
group (4350 ml [2790–6160 ml]) than in the 
usual care group (median 5080 ml [3930–
7320 ml] {p=0.02}). There was no 
significant difference in any outcomes 
between the two groups. 
Findings were summarized and presented 
well with the use of tables. 
Findings may facilitate future meta-analysis. 
Discussion 
Interpretation of the 
findings 
• Were all major findings interpreted and discussed 
within the context of prior research and/or the study’s 
conceptual framework? 
• Were casual inferences, if any, justified? 
• Was the issue of clinical significance discussed? 
• Were interpretations well-founded and consistent 
with the study’s limitations? 
The findings were discussed within context 
of previous research. 
Clinical significance and generalizability 
were discussed. 
The researchers suggested that by using 
advanced hemodynamic monitoring 
strategies, fluid administration volumes can 
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• Did the report address the issue of the 
generalizability of the findings? 
be individualized to patient need, and 
overall volumes of fluid can be reduced. 
The researchers suggested that the results 
are generalizable as all patients presenting 
for cardiac surgery were invited for 
enrollment, with small percentage of 
declines, and no loss to follow up. 
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and were 
those implications reasonable and complete? 
The researchers discussed the implications 
of this feasibility study in clinical practice 
and for further research. They recommended 
large, appropriately powered studies that 
utilize a conservative fluid management 
strategy in cardiac surgery patients. 
General Issues 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the study? 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was used. 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
The study has been published in a peer 
reviewed journal. The researchers have 
background in research and in 
cardiothoracic intensive care. 
Summary assessment • Despite any limitations, do the study findings appear 
to be valid 
• Does the study contribute any meaningful evidence 
that can be used in nursing practice or that is useful to the 
nursing discipline? 
The study findings do appear to be valid 
despite its limitations. 
Note. CPB= cardiopulmonary bypass; GDT= goal directed therapy; SVV=stroke volume variation; CI= cardiac index; 
IVF=intravenous fluid. 
 
      118 
Table C-5 
Walker & Young, 2015. Fluid administration, vasopressor use and patient outcomes in a group of high-risk cardiac surgical patients 
receiving postoperative goal-directed haemodynamic therapy: a pilot study. 
 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title clearly identified the key variables, 
the intervention, and the study population. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, results, 
conclusions)? 
The abstract outlined all the components of 
the study. 
Introduction 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Is the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used –that is, was a quantitative 
approach appropriate? 
The problem was stated clearly and it argued 
the necessity for further study. A 
quantitative approach was the most 
appropriate method to study this problem 
Hypotheses or 
research questions 
• Were research questions and/or hypotheses 
explicitly stated?  If not, was their absence justified? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and the 
study population? 
• Were the questions/hypotheses consistent with 
existing knowledge? 
The hypothesis as well as the key variables 
were stated clearly. The researchers 
hypothesized that a GDT protocol could 
reduce vasopressor duration, and optimize 
fluid administration in high risk cardiac 
surgery patients. 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
• Did the literature review provide a strong basis for 
the new study? 
The literature review was limited, but was 
based mainly on primary sources. 
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Conceptual/theoretical 
framework 
• Were key concepts adequately defined 
conceptually? 
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is the 
absence of a framework justified? 
• Were the questions/hypotheses consistent with the 
framework? 
No conceptual framework was articulated. 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? 
• Was the study externally reviewed by an IRB/ethics 
review board? 
• Was the study designed to minimize risks and 
maximize benefits to participants? 
The research was approved by the Health 
and Disability Ethics Committee of New 
Zealand. Written informed consent was 
obtained from eligible patients. 
Research design • Was the most rigorous design used, given the study 
purpose? 
• Were appropriate comparisons made to enhance 
interpretability of the findings? 
• Was the number of data collection points 
appropriate? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study (e.g., 
was blinding used, was attrition minimized)? 
This was an interventional pilot study, that 
was a sub-study of a larger research project. 
It compared a prospective cohort with a 
similar retrospective cohort, and therefore is 
not as rigorous as an RCT would have been. 
It was a single-center trial therefore results 
have limited external validity. In addition, 
the prospective/retrospective comparison 
design allowed for possible staffing and 
practice differences between the two groups. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the best possible sampling design used to 
enhance the sample’s representativeness?  Were sampling 
biases minimized? 
• Was the sample size based on a power analysis? 
The population and sample were identified 
and described in detail. The population 
comprised high risk cardiac surgery patients 
older than 18 years of age. The study group 
included 40 patients in the prospective 
cohort who received the intervention. It was 
compared to a matched group that had 
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surgery a year earlier and which received 
“usual care”. This group was considered to 
be the control group. 
A power analysis was not performed. 
Data collection and 
measurement 
 
 
 
• Were the operational and conceptual definitions 
congruent? 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described and 
were they good choices, given the study population and the 
variables being studied? 
• Did the report provide evidence that the data 
collection methods yielded data that were reliable, valid and 
responsive? 
The primary outcome was duration of post-
operative noradrenaline infusion. The 
secondary outcomes included 12 hour 
amount of IVF,  duration of mechanical 
ventilation, rate of reintubation, 24 hour 
dose of noradrenaline, peak S. creatinine 
and the duration of ICU stay. 
Data from the prospective cohort was 
collected by a research nurse from the OR 
and the ICU. Data from the retrospective 
cohort were recorded by the research 
physician from historical patient notes. 
These methods were appropriate for this 
research design. 
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there evidence 
of intervention fidelity? 
• Were data collected in a manner that minimized 
bias?  Were the staff who collected data appropriately 
trained? 
 The intervention was described adequately. 
It consisted of administration of fluid bolus 
of 5 ml/kg if CI <2.0, SVo2<60 %, MAP 
<65. If volume unresponsive, vasopressors, 
inotropes or blood transfusion would be 
considered. 
 All the patients in the intervention group 
received the intervention. However the data 
recorded for some variables were 
incomplete in the records, and therefore the 
cohort size for those variables was 
decreased. 
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Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
• Were appropriate statistical methods used, given the 
level of measurement of the variables, number of groups 
being compared, and assumptions of the texts? 
• Was a powerful analytic method used?  (e.g., did the 
analysis help to control for confounding variables)? 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
• Were problems of missing values evaluated and 
adequately addressed? 
•  
Analyses was undertaken to address each 
research question. Appropriate statistical 
methods were used. Nonparametric Mann–
Whitney U test was used to compare sample 
medians. Normally distributed data were 
compared by analysis of variance.  
Categorical data were compared using the 
chi-squared test. Small-sample categorical 
data were compared with Fisher’s exact test.  
A two-sided p value less than 0.05 was 
considered statistically significant. 
There was no discussion of methods to 
minimize type I and II errors. 
Intention-to-treat analysis was not 
performed. 
Findings • Was information about statistical significance 
presented?  Was information about effect size and precision 
of estimates (confidence intervals) presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates a 
meta-analysis, and with sufficient information needed for 
EBP? 
Findings were presented with information 
about statistical significance, however there 
was no data on effect size. The results 
showed that the GDT group received 
significantly (p <0.001) more fluid 
(4687±2284) in the first 12 hours 
postoperatively than the usual care cohort 
(1189±1344 ml). It also had a significantly 
(p=0.049) higher rate of reintubation (4 in 
37 [10.8%]) vs. the usual care group (0 in 40 
[0%]) 
There was good use of tables.  
Data may not be useful for meta-analyses 
because of the retrospective research design. 
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Discussion 
Interpretation of the 
findings 
• Were all major findings interpreted and discussed 
within the context of prior research and/or the study’s 
conceptual framework? 
• Were casual inferences, if any, justified? 
• Was the issue of clinical significance discussed? 
• Were interpretations well-founded and consistent 
with the study’s limitations? 
• Did the report address the issue of the 
generalizability of the findings? 
The findings were discussed within context 
of previous research. 
Clinical significance and generalizability 
were discussed. The researchers suggested 
that the results may not be generalizable to 
all cardiac surgical patients because of the 
small study size, use of a specific protocol, 
and the high-risk population that was 
targeted. 
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and were 
those implications reasonable and complete? 
The study findings implied that the 
intervention increased complications, and 
therefore it resulted in cessation of the 
intervention. No further research 
implications were discussed. 
General Issues 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the study? 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was not used. 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
Study was published in a peer reviewed 
academic journal. Both the researchers are 
ICU intensivists. 
Summary assessment • Despite any limitations, do the study findings appear 
to be valid—do you have confidence in the truth value of 
the results? 
• Does the study contribute any meaningful evidence 
that can be used in nursing practice or that is useful to the 
nursing discipline? 
The study findings do appear to be valid 
despite its limitations. 
Note. RCT= randomized controlled trial; GDT= goal directed therapy; CI= cardiac index; IVF=intravenous fluid; MAP=mean arterial 
pressure; Svo2= mixed venous oxygen saturation 
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Table C-6 
Shrestha et al., 2015. A prospective randomized study of goal oriented hemodynamic therapy in cardiac surgical patients. 
 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title clearly identified the intervention 
and the study population, but not the 
dependent variables/outcomes. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, results, 
conclusions)? 
The abstract outlined all the components of 
the study clearly and concisely 
Introduction 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Is the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used –that is, was a quantitative 
approach appropriate? 
The researchers did not made a case for why 
a new study was required. They briefly 
discussed the research in this area and then 
stated the aim of the study, which was to 
evaluate early post- operative outcomes in 
cardiac surgery patients after the adoption of 
an early goal directed hemodynamic 
therapy. 
In studying this area, a quantitative 
approach was the most appropriate method. 
Hypotheses or 
research questions 
• Were research questions and/or hypotheses 
explicitly stated?  If not, was their absence justified? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and the 
study population? 
• Were the questions/hypotheses consistent with 
existing knowledge? 
The researchers did not state a hypothesis. 
The aim of the study was to evaluate early 
post- operative outcomes in cardiac surgery 
patients after the adoption of an early goal 
directed hemodynamic therapy. 
 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
The study had a brief literature review, and 
mainly used primary sources. It provided a 
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• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
• Did the literature review provide a strong basis for 
the new study? 
good summary of the current evidence that 
has emerged in this area of science. 
Conceptual/theoretical 
framework 
• Were key concepts adequately defined conceptually? 
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is the 
absence of a framework justified? 
• Were the questions/hypotheses consistent with the 
framework? 
No conceptual framework was articulated. 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? 
• Was the study externally reviewed by an IRB/ethics 
review board? 
• Was the study designed to minimize risks and 
maximize benefits to participants? 
The study was approved by IRB/ethics 
board. Informed consent was obtained prior 
to the study. 
Research design • Was the most rigorous design used, given the study 
purpose? 
• Were appropriate comparisons made to enhance 
interpretability of the findings? 
• Was the number of data collection points 
appropriate? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study (e.g., 
was blinding used, was attrition minimized)? 
The study design was a prospective RCT. 
Blinding was not possible because the 
intervention being used required specific 
devices. External validity was limited 
because it was a single center study. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the best possible sampling design used to 
enhance the sample’s representativeness?  Were sampling 
biases minimized? 
The population was identified details are 
provided. It consisted of patients between 
the ages of 15 and 75 years, undergoing 
open cardiac surgery, including CABG and 
valve surgeries. There were 100 patients 
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• Was the sample size based on a power analysis? enrolled in the study with 50 in the 
experimental group and 50 in the control 
group. 
The sample size was based on power 
analysis. 
Data collection and 
measurement 
 
 
 
• Were the operational and conceptual definitions 
congruent? 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described and 
were they good choices, given the study population and the 
variables being studied? 
• Did the report provide evidence that the data 
collection methods yielded data that were reliable, valid and 
responsive? 
Details about data collection were not 
provided. Data was presumed to have been 
obtained from specific monitoring devices 
that were used and from medical records. 
Outcome indicators included mortality, 
length of ICU and hospital stay, use of 
ventilator, use of inotropes, organ 
dysfunctions, need for hemodialysis and 
wound complication. 
 
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there evidence 
of intervention fidelity? 
• Were data collected in a manner that minimized 
bias?  Were the staff who collected data appropriately 
trained? 
Intervention was described in detail and 
adequately in the study. It consisted of fluid 
bolus 100 ml administered if CI < 2.2 
l/min/m2, CVP < 6 mmHg or SVV >10%. 
The study did not explicitly state if the study 
group participants all received the 
interventions.  
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
• Were appropriate statistical methods used, given the 
level of measurement of the variables, number of groups 
being compared, and assumptions of the texts? 
• Was a powerful analytic method used?  (e.g., did the 
analysis help to control for confounding variables)? 
Appropriate statistical methods were used to 
analyze data.  
 Student unpaired t test, Chi square test, and 
one way ANOVA were used as appropriate. 
P value less than 0.05 were considered 
significant. 
      126 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
• Were problems of missing values evaluated and 
adequately addressed? 
There was no discussion of methods to 
minimize type I and II errors. 
 Intention-to-treat analysis was not 
performed. 
Findings • Was information about statistical significance 
presented?  Was information about effect size and precision 
of estimates (confidence intervals) presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates a 
meta-analysis, and with sufficient information needed for 
EBP? 
Findings were presented with information 
about statistical significance and precision 
of estimates with CI of 95 %.  
There was a significant (p=0.041) reduction 
in ventilator time in the study group ([M] 
10.48 ± [S.D] 7.640 hours) compared to the 
control group (16.429 ± 11.801hours).  The 
duration of inotrope usage was also 
significantly (p=0.032) lower in the study 
group (23.2 ± 17.870 hours ) than in the 
control group (39.12 ± 18.615 hours). 
There was good use of tables and the data 
may be useful for future meta-analyses. 
Discussion 
Interpretation of the 
findings 
• Were all major findings interpreted and discussed 
within the context of prior research and/or the study’s 
conceptual framework? 
• Were casual inferences, if any, justified? 
• Was the issue of clinical significance discussed? 
• Were interpretations well-founded and consistent 
with the study’s limitations? 
• Did the report address the issue of the 
generalizability of the findings? 
The findings were discussed within context 
of previous research, and the clinical 
significance of the study was discussed. 
The study was limited because it was single 
centered, and blinding was not possible. It 
also did not stratify the patients who were at 
higher risk, and included different types of 
cardiac surgeries, all of which could reduce 
validity and generalizability. 
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Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and were 
those implications reasonable and complete? 
The researchers discussed the implications 
of the study in clinical practice, but not 
those for further research. They suggested 
the  implementation of  perioperative goal-
directed strategies as part of quality 
improvement programs.  
General Issues 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the study? 
• Was the report written in a manner that makes the 
findings accessible to practicing nurses? 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was not used. 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
Study was published in an academic journal, 
however this article has not been peer 
reviewed. The researchers are cardiothoracic 
and vascular surgery physicians. 
Summary assessment • Despite any limitations, do the study findings appear 
to be valid—do you have confidence in the truth value of 
the results? 
• Does the study contribute any meaningful evidence 
that can be used in nursing practice or that is useful to the 
nursing discipline? 
The study findings do appear to be valid 
despite its limitations. 
Note. RCT= randomized controlled trial; CABG= coronary artery bypass graft; CI= cardiac index; CVP=central venous pressure; 
SVV=stroke volume variation; SD=standard deviation. 
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 Table C-7 
 Osawa et al., 2016. Effect of Perioperative Goal-Directed Hemodynamic Resuscitation Therapy on Outcomes Following Cardiac 
Surgery: A Randomized Clinical Trial and Systematic Review. 
 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title clearly identified the intervention 
and the study population. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, results, 
conclusions)? 
The abstract outlined all the components of 
the study clearly and concisely. 
Introduction 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Is the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used –that is, was a quantitative 
approach appropriate? 
The researchers briefly but clearly states the 
problem and the need for the new study.   
They used a quantitative method to study 
this problem, which was appropriate for the 
nature of the study. 
Hypotheses or 
research questions 
• Were research questions and/or hypotheses 
explicitly stated?  If not, was their absence justified? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and the 
study population? 
• Were the questions/hypotheses consistent with 
existing knowledge? 
The researchers did not state a hypothesis. 
They stated that the aim of the study was to 
investigate whether a GDT protocol was 
superior to standard care in high-risk 
patients undergoing cardiac surgery. 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
The study had a brief review of literature 
that was used to introduce the problem and 
the intervention. It was based mainly on 
primary sources. It did not provide an up-to-
date synthesis of evidence on the problem. 
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• Did the literature review provide a strong basis for 
the new study? 
Conceptual/theoretical 
framework 
• Were key concepts adequately defined conceptually? 
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is the 
absence of a framework justified? 
• Were the questions/hypotheses consistent with the 
framework? 
No conceptual framework was articulated. 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? 
• Was the study externally reviewed by an IRB/ethics 
review board? 
• Was the study designed to minimize risks and 
maximize benefits to participants? 
Study protocol was approved by the Heart 
Institute Ethics Committee in accordance 
with the Helsinki Declaration of the World 
Medical Association and informed consent 
was obtained prior to study enrollment. 
Research design • Was the most rigorous design used, given the study 
purpose? 
• Were appropriate comparisons made to enhance 
interpretability of the findings? 
• Was the number of data collection points 
appropriate? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study (e.g., 
was blinding used, was attrition minimized)? 
A prospective RCT design was used. 
Eligible patients were randomly assigned to 
receive either GDT or usual care. 
While blinding not feasible for those 
administering the intervention, outcome 
assessors were blinded to study-group 
assignments. 
This was a single-center trial conducted in a 
cardiology reference hospital, therefore the 
results had limited external validity. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the best possible sampling design used to 
enhance the sample’s representativeness?  Were sampling 
biases minimized? 
• Was the sample size based on a power analysis? 
The population sample was identified and 
described in detail. The study had 126 high 
risk patients undergoing CABG and/or 
valvular surgery, over the age of 18, with 62 
assigned to the GDT group and 64 to the 
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usual care group. Sample size was based on 
power analysis. 
Data collection and 
measurement 
 
 
 
• Were the operational and conceptual definitions 
congruent? 
• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described and 
were they good choices, given the study population and the 
variables being studied? 
• Did the report provide evidence that the data 
collection methods yielded data that were reliable, valid and 
responsive? 
Independent variables were measured using 
appropriate hemodynamic measurement 
instruments. 
Dependent variables were presumed to have 
been obtained from medical records. 
The primary outcome was the 30-day 
mortality and major post-op complications. 
The secondary outcomes included 30-day 
incidence of delirium, venous 
thromboembolism, seizure, and AKI. 
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there evidence 
of intervention fidelity? 
• Were data collected in a manner that minimized 
bias?  Were the staff who collected data appropriately 
trained? 
 Intervention was described in detail and 
adequately in the study.  It involved 
administration of 250 ml fluid bolus for CI 
<3.0 and SVI < 35 mL/m2. If CI remained 
<3.0, but the SVI was >35 mL/m2 then 
dobutamine infusion was administered. 
 Most of the participants allotted to the 
study group received the intervention, with 
only 1 out of the 62 being managed 
according to standard care because of  an 
equipment issue. 
Data was collected by three blinded 
assessors who were experienced in the 
cardiac surgery ICU. 
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
 Primary and the secondary outcomes were 
all analyzed. Appropriate statistical methods 
were used. Continuous variables were 
reported as mean SD or medians with IQR 
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• Were appropriate statistical methods used, given the 
level of measurement of the variables, number of groups 
being compared, and assumptions of the texts? 
• Was a powerful analytic method used?  (e.g., did the 
analysis help to control for confounding variables)? 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
• Were problems of missing values evaluated and 
adequately addressed? 
•  
and categorical variables as proportions. 
Continuous variables were compared using 
Student t test or Mann-Whitney U test. 
Categorical variables used Pearson chi-
square or Fisher exact test. 
A two-sided p value less than 0.05 was 
considered statistically significant. 
All analyses were conducted according to 
the intention-to-treat principle without 
assumptions being made for missing or 
unavailable data. 
Findings • Was information about statistical significance 
presented?  Was information about effect size and precision 
of estimates (confidence intervals) presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates a 
meta-analysis, and with sufficient information needed for 
EBP? 
The results showed that the GDT  group had 
significantly (p=0.002) lower rate of 
infection (12.9%) compared to the usual 
care group (29.7%), and significantly 
(p=0.003) reduced incidence of low cardiac 
output syndrome (6.5% in the GDT group 
vs 26.6% in the usual care group). The GDT 
group also had significantly (p = 0.003) 
lower cumulative dosage of inotrope 12 in 
GDT group vs 19 mg/kg in the usual care 
group), and a significantly (p = 0.049) 
shorter ICU (3 days in the GDT group vs. 5 
days in the usual care group) and hospital 
length of stay ([9 days in the GDT group vs 
12 days in the usual care group] p = 0.049). 
The findings were presented with 
information about statistical significance, 
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however there was no data on effect size. 
There was good use of tables.  
The data will allow for future meta-
analyses. 
Discussion 
Interpretation of the 
findings 
• Were all major findings interpreted and discussed 
within the context of prior research and/or the study’s 
conceptual framework? 
• Were casual inferences, if any, justified? 
• Was the issue of clinical significance discussed? 
• Were interpretations well-founded and consistent 
with the study’s limitations? 
• Did the report address the issue of the 
generalizability of the findings? 
Findings were discussed within context of 
previous research. Clinical significance and 
generalizability were discussed. 
The researchers suggested that a GDT 
started early in the OR and continued into 
the immediate postoperative period may 
reduce complications in high risk cardiac 
surgery. 
They acknowledged that the results may 
have limited external validity by virtue of 
being a single-center trial, conducted in a 
cardiology reference hospital.  
Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and were 
those implications reasonable and complete? 
The researchers discussed the implications 
of the study for further research. They 
recommended future studies that use GDT 
beyond the first few immediate post-
operative hours. This trial only continued 
GDT up to 8 hours post-operatively. They 
also recommended multimodal monitoring 
techniques that can detect early organ 
dysfunction in these future trials. 
General Issues 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the study? 
The report was written and organized well 
and allowed for critical analysis. 
 
CONSORT flow chart was used. 
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• Was the report written in a manner that makes the 
findings accessible to practicing nurses? 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
Study was published in a peer reviewed 
academic journal. Many of the researchers 
have advanced medical degrees and PhDs 
and are affiliated with research university 
hospitals in Brazil, UK, Germany and Italy. 
Summary assessment • Despite any limitations, do the study findings appear 
to be valid—do you have confidence in the truth value of 
the results? 
• Does the study contribute any meaningful evidence 
that can be used in nursing practice or that is useful to the 
nursing discipline? 
The study findings do appear to be valid 
despite its limitations. 
Note. RCT= randomized controlled trial; CABG= coronary artery bypass graft; GDT= goal directed therapy; AKI=acute kidney 
injury; IQR=interquartile range; SD=standard deviation. 
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Table C-8 
Kapoor et al., 2016. Perioperative utility of goal-directed therapy in high-risk cardiac patients undergoing coronary artery bypass 
grafting:“A clinical outcome and biomarker-based study”. 
 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title • Is the title a good one, succinctly suggesting key 
variables and the study population? 
The title clearly identified the intervention 
and the study population. 
Abstract • Did the abstract clearly and concisely summarize the 
main features of the report (problem, methods, results, 
conclusions)? 
The abstract outlined all the components of 
the study clearly and concisely. 
Introduction 
Statement of the 
problem 
• Was the problem stated unambiguously, and was it 
easy to identify? 
• Is the problem statement build a persuasive 
argument for the new study? 
• Was there a good match between the research 
problem and the methods used –that is, was a quantitative 
approach appropriate? 
The researchers briefly described the 
problem and built a reasonable argument for 
the new study. They used a quantitative 
method to study this problem, which was 
appropriate for the nature of the study. 
Hypotheses or 
research questions 
• Were research questions and/or hypotheses 
explicitly stated?  If not, was their absence justified? 
• Were questions and hypotheses appropriately 
worded, with clear specification of key variables and the 
study population? 
• Were the questions/hypotheses consistent with 
existing knowledge? 
No hypothesis was stated. The aim of the 
study was to evaluate the utility of a GDT in 
high risk cardiac surgery patients. 
 
Literature review • Was the literature review up-to-date and based 
mainly on primary sources? 
• Did the review provide a state-of-the-art synthesis of 
evidence on the problem? 
• Did the literature review provide a strong basis for 
the new study? 
The study had a brief review of literature 
that was used to introduce the problem and 
the intervention. It did not provide an up-to-
date synthesis of evidence on the problem. 
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Conceptual/theoretical 
framework 
• Were key concepts adequately defined conceptually? 
• Was a conceptual/theoretical framework 
articulated—and, if so, was it appropriate?  If not, is the 
absence of a framework justified? 
• Were the questions/hypotheses consistent with the 
framework? 
No conceptual framework was articulated. 
Method 
Protection of human 
rights 
• Were appropriate procedures used to safe-guard the 
rights of study participants? 
• Was the study externally reviewed by an IRB/ethics 
review board? 
• Was the study designed to minimize risks and 
maximize benefits to participants? 
Ethical clearance form IRB and  informed 
consent from the patients was obtained prior 
to the study. 
Research design • Was the most rigorous design used, given the study 
purpose? 
• Were appropriate comparisons made to enhance 
interpretability of the findings? 
• Was the number of data collection points 
appropriate? 
• Did the design minimize biases and threats to the 
internal, construct, and external validity of the study (e.g., 
was blinding used, was attrition minimized)? 
The study used a prospective RCT design. 
Blinding was not possible because of the 
nature of the intervention. The researchers 
did not state any specific precautions taken 
to reduce bias or threats to validity. 
Population and 
sample 
• Was the population identified?  Was the sample 
described in sufficient detail? 
• Was the best possible sampling design used to 
enhance the sample’s representativeness?  Were sampling 
biases minimized? 
• Was the sample size based on a power analysis? 
The population and sample were identified 
and basic characteristics were provided in a 
table. The sample consisted of 130 high risk 
patients undergoing CABG on CPB. 
Data collection and 
measurement 
 
• Were the operational and conceptual definitions 
congruent? 
The study did not provide information 
regarding how the data was collected or 
measured. The study mentioned that some 
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• Were key variables measured using an appropriate 
method (e.g., interviews, observations, and so on)? 
• Were specific instruments adequately described and 
were they good choices, given the study population and the 
variables being studied? 
• Did the report provide evidence that the data 
collection methods yielded data that were reliable, valid and 
responsive? 
data was collected from medical records and 
by contacting patients via telephone after 
discharge. Presumably much of the data was 
obtained through monitoring devices, and 
possibly via direct observation. 
The primary outcome was fitness to be 
discharged from the ICU. Secondary 
outcomes included post-operative 
complications and the need for vasopressor 
support.  
Procedures • If there was an intervention, was it adequately 
described, and was it rigorously developed and 
implemented?  Did most participants allocated to the 
intervention group actually receive it?  Was there evidence 
of intervention fidelity? 
• Were data collected in a manner that minimized 
bias?  Were the staff who collected data appropriately 
trained? 
 The intervention was described well and 
appears well designed. It involved 
administering a fluid bolus of 100 ml if CI < 
2.2 l/min/m2, CVP < 6 mmHg or SVV 
>10%. Five patients in the study group were 
excluded from the study because of certain 
complications that they developed. 
Data Analysis • Were analyses undertaken to address each research 
question or test each hypothesis? 
• Were appropriate statistical methods used, given the 
level of measurement of the variables, number of groups 
being compared, and assumptions of the texts? 
• Was a powerful analytic method used?  (e.g., did the 
analysis help to control for confounding variables)? 
• Were type I and Type II errors avoided or 
minimized? 
• In intervention studies, was an intention-to-treat 
analysis performed? 
Detailed analysis of outcome variables was 
conducted.  
Appropriate statistical methods were used. 
Data was presented as number, percentage, 
mean, SD, median, IQR. 
Tests used included t test, Mann Whitney U 
test, Wilcoxon signed-rank test, Pearson’s 
Chi- square test and Fisher’s exact test. 
P value less than 0.05 was considered 
significant. 
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• Were problems of missing values evaluated and 
adequately addressed? 
There was no discussion on measures to 
minimize type I and II errors.  Intention-to-
treat analysis was not performed. 
Findings • Was information about statistical significance 
presented?  Was information about effect size and precision 
of estimates (confidence intervals) presented? 
• Were the findings adequately summarized, with 
good use of tables and figures? 
• Were findings reported in a manner that facilitates a 
meta-analysis, and with sufficient information needed for 
EBP? 
Findings were presented with information 
about statistical significance.  
The results showed that the GDT arm had a 
significantly (p < 0.001) shorter length of 
hospital stay (7.42 ± 1.48 days) compared to 
the conventional arm (5.61 ± 1.11 days). 
The GDT group also had a significantly (p < 
0.001) shorter length of ICU stay (4.2 ± 
0.82) compared to the conventional arm 
(2.53 ± 0.56 days), and significantly (p = 
0.005) lower duration of inotrope usage 
(3.24 ± 0.73 hours) compared to the 
conventional arm (2.89 ± 0.68 hours). 
There was good use of tables.  
The findings were presented in a manner 
that may facilitate future meta-analysis. 
Discussion 
Interpretation of the 
findings 
• Were all major findings interpreted and discussed 
within the context of prior research and/or the study’s 
conceptual framework? 
• Were casual inferences, if any, justified? 
• Was the issue of clinical significance discussed? 
• Were interpretations well-founded and consistent 
with the study’s limitations? 
• Did the report address the issue of the 
generalizability of the findings? 
The findings were discussed within context 
of previous research, and the clinical 
significance of the study was discussed. 
The researchers suggested that perioperative 
GDT can shorten the duration of ventilator 
dependency, ICU and hospital stay in high-
risk cardiac surgical patients. 
The report did not address the issue of 
generalizability of the findings. 
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Implications/ 
recommendations 
• Did the researchers discuss the implications of the 
study for clinical practice or further research—and were 
those implications reasonable and complete? 
The researchers discussed the implications 
of the study in clinical practice, as well as 
for further research. They recommended 
future studies that include the use of volume 
status markers such as extravascular lung 
volume. 
General Issues 
Presentation 
• Was the report well-written, organized, and 
sufficiently detailed for critical analysis? 
• In intervention studies, was a CONSORT flowchart 
provided to show the flow of participants in the study? 
• Was the report written in a manner that makes the 
findings accessible to practicing nurses? 
The report was written and organized well 
and allowed for critical analysis. 
CONSORT flow chart was not used, 
however the study had a flow chart that 
combined patient allocation with the 
intervention and the usual care details. 
Researcher credibility • Do the researchers’ clinical, substantive, or 
methodologic qualifications and experience enhance 
confidence in the findings and their interpretation? 
The study was published in an academic 
journal, and has been peer reviewed. The 
researchers are physicians in cardiac 
anesthesia and critical care areas. 
Summary assessment • Despite any limitations, do the study findings appear 
to be valid—do you have confidence in the truth value of 
the results? 
• Does the study contribute any meaningful evidence 
that can be used in nursing practice or that is useful to the 
nursing discipline? 
The study findings do appear to be valid 
despite its limitations. 
 
Note. RCT= randomized controlled trial; CABG= coronary artery bypass graft; CPB= cardiopulmonary bypass; GDT= goal directed 
therapy; SVV=stroke volume variation; CI=cardiac index; IQR=interquartile range; SD=standard deviation. 
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Appendix D 
 
Cross Analysis of Studies that Surveyed Practices in Cardiac Surgery  
 
Table D-1 
Basic Information and Goals of the Surveys 
 
First 
author 
Year Country Design Goal Number of questionnaires or 
participants 
Kastrup  2012 Germany Postal 
Survey 
Evaluate hemodynamic monitoring, 
volume replacement, vasopressor and 
inotropic usage in clinical practice. 
62 
Sponholz 2014 Germany Postal survey Evaluate hemodynamic monitoring,  
fluid monitoring and volume therapy. 
50 
Bignami 2015 Italy Fax and 
email 
Evaluate hemodynamic monitoring,  
fluid monitoring and volume therapy. 
81 
Protsyk 2017 18 European 
countries 
Online 
survey 
Evaluate fluid therapy choices. 106 
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Table D-2. 
Survey Results on Volume Monitoring Methods Used and Fluids Used for Volume Replacement 
 
First 
author 
Volume monitoring methods used Fluid types 
Kastrup  Increased use of Systolic pressure variation, TEE, and 
extravascular lung water in 2012 compared to 2005. 
 
Reduction in the use of HES with 38.7% in 2012 
compared to 63.4% in 2005, and a corresponding 
significant increase in the use of crystalloids ; 41.9% in 
2012 compared to 22.4% in 2005. 
 
Sponholz Undulating arterial pressure curve, CVP and TEE used 
most. 
 
Crystalloids were the fluids of first choice during and after 
surgery (median 2), followed by HES (median 3). 
 
Bignami BP, CVP, echocardiography used most. 
 
The first choice for volume replacement were crystalloid 
solutions in 86.8 %, followed by artificial colloids in 
11.8 % of the centers. The second choice was artificial 
colloids in 66.7 % of centers, HES being the most 
frequently used. 
Protsyk Not obtained. 
 
Balanced crystalloids most frequently used for 
intraoperative management than were other solutions 
(74%) followed by a combination of crystalloids and 
synthetic colloids (15%). When colloids were used, 
gelatin was preferred to HES or albumin (60% vs. 24 % 
vs. 16%) respectively. 
 
 
Note. CVP=central venous pressure; TEE= transesophageal echocardiography; HES= hydroxyethyl starch; BP=blood pressure. 
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Appendix E 
 
Goal Directed Therapy in Cardiac Surgery 
 
Table E-1 
Goal directed therapy: Basic information 
First Author, 
Year 
Country  Study Type Type of surgery Number of participants Timing  
Goepfert, 2013 Germany Prospective RCT CABG and/or valve surgery Control group 50 
Study group 50 
Intraoperative 
Fellahi, 2015 France Prospective RCT Elective CABG with CPB  Control group-44 
Study group-48 
Intraoperative 
Thomson, 2014 United 
Kingdom 
Prospective 
observational study 
CABG and/or aortic valve 
surgery; both on and off 
pump. 
Standard therapy- 141 
GDT-123 
Postoperative 
Parke, 2015 Australia/
New 
Zealand 
Prospective randomized 
feasibility study 
Elective cardiac surgery with 
CPB 
Usual Care -74 
Study group-70 
Postoperative 
Walker, 2015 New 
Zealand 
Prospective 
interventional study 
compared with 
retrospective cohort 
High risk cardiac surgery Usual Care- 40 
Study group-40 
Postoperative 
Shrestha, 2015 Nepal Prospective RCT Cardiac surgery Usual Care-15 
Study group-20 
Intraoperative and 
Postoperative 
Osawa, 2016 Brazil Prospective RCT High risk cardiac surgery Usual care-64 
Study group-62 
Intraoperative and 
postoperative 
Kapoor, 2017 India Prospective RCT CABG on CPB Control 60 
GDT  60 
Intraoperative and 
postoperative 
Note. RCT= randomized controlled trial; CABG= coronary artery bypass graft; CPB= cardiopulmonary bypass; GDT= goal directed 
therapy. 
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Table E-2 
Hemodynamic monitoring and therapy goals 
 
First 
author 
Goals for therapy and intervention in GDT group Usual Care 
Goepfert Administer fluid until SVV< /10% is reached unless ELWI >12 in 
which case fluid is stopped. If SVV<10, but CI > 2.0, then 
administer vasopressors, atropine, RBC, or pace as appropriate. 
Administer fluid for CVP< 8.  If CVP> 8 and MAP< 
65, initiate catecholamines. 
Fellahi Administer 100 ml fluid bolus for SVV> 11. After correcting SVV 
to <11, measure CI. If CI<2.4 start dobutamine. 
Fluid administration based on BP, CVP, urine output, 
skin mottling, and arterial pulse pressure variation. 
Thomson Record baseline SV, CO, CVP, then administer 250 ml of fluid 
bolus. If SV increases by >/10 % repeat bolus.  
Fluid administration based on perceived clinical need, 
MAP, CVP, lactate level, urine output, base deficit. 
Parke Administer fluid bolus (250- 500 ml) for CI < 2.5 and SVV>13.  
If not, and MAP<65, consider starting vasoconstrictor. 
Fluid administration up to 2 liters by nurses based on 
clinical judgment, MAP or CVP. 
Walker Administer fluid bolus of 5 ml/kg if  
CI <2.0, SVo2<60 %, MAP <65. If volume unresponsive consider 
vasopressors, inotropes or blood transfusion. 
No data 
Shrestha Fluid bolus 100 ml administered if CI < 2.2 l/min/m2, CVP < 6 
mmHg or SVV >10%. 
CVP, MAP, ABG analysis, hematocrit, urine output 
Osawa Fluid bolus 250 ml administered if CI <3.0 and SVI < 35 mL/m2. 
If CI remains <3.0, but the SVI is >35 mL/m2 then start 
dobutamine infusion. 
HR 70-100 
ScVo2 >70 % 
Lactate level<3 
Urine output > 0.5 ml/kg/hr 
MAP >/ 65 
Kapoor Fluid bolus 100 ml administered if CI < 2.2 l/min/m2, CVP < 6 
mmHg or SVV >10%. Until goals achieved. 
CVP, MAP, EtCO2, temp, ABG analysis, hematocrit, 
urine output. 
 
Note. GDT=goal directed therapy; SVV= stroke volume variation; SVI= stroke volume index; SV=stroke volume; CO= cardiac 
output; SvO2=mixed venous oxygen saturation; EVLWI= extravascular lung water index; CI= cardiac index; MAP= mean arterial 
pressure; RBC= red blood cells; CVP= central venous pressure; ABP= arterial blood gas; EtCO2= end tidal. 
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Table E-3 
Fluid Data  
 
First 
author 
Timing/hours Fluid  GDT/ Study group. Usual care/Control group.  P value 
Goepfert From induction 
until ICU discharge 
 
 
 
 
Intraoperative 
alone 
 
ICU fluid therapy 
Total fluids 
 
Total Crystalloids 
Total colloids 
 
Crystalloids 
Colloids 
 
 
Crystalloids 
Colloids 
Mean ± SD, [Median] (11,701 ± 
2,175 [11,325] ml 
3,698 ± 1,121 [3,700] 
3,067 ± 1,165 [3,000] 
 
2,168 ± 554 [2,000] ml 
1,293 ± 501 [1,500] ml 
 
 
1,529 ± 947 [1,500] ml 
1,774 ± 996 [1,500] ml 
12,313 ± 3,281 [11,746] ml 
 
4,451 ± 2,608 [4,000] 
2,117 ± 1,062 [2,000] ml 
 
2,028 ± 535 [2,000] ml 
880 ± 397 [1,000] ml 
 
 
2,423 ± 2,470 [2,000] ml 
1,237 ± 988 [1,000] ml 
0.227 
 
0.34 
<0.001 
 
0.36 
<0.001 
 
 
0.16 
0.008 
Fellahi Intraoperative 
period 
 
 
Total fluid 
loading 
 
Patients ( fluid 
loading) 
mean ± SD 400 [200–1,000] 
 
 
 
41 (85) 
500 [100–1,100 
 
 
 
30 (68) 
 
0.035 
 
 
 
0.042 
Thomson Postoperative 8 
hours 
Total fluids 
 
2704 (1393) mL 2905 (1367) mL 0.09 
Parke Post-op until 
extubation. 
 
 
 
Post op until 24 
hours.  
Bolus fluid 
 
Total fluid 
 
 
Bolus fluid 
 
median (IQR) 1620 ml (500–3410 
ml) 
 
2050 (910–4280 
 
2760 ml (1690–4500), 
 
2520 ml (1440–5250) 
 
 
2980 (2070–6580 
 
 
3750 ml (2250–5550, 
<0.001 
 
 
0.001 
 
 
0.02 
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Total fluid 4350 (2790–6160  
 5080 (3930–7320) 
 
0.002 
Walker First 12 hours Total fluid 
 
Mean SD 4687 ± 2284 1189 ± 1344 <0.001 
Shrestha From opening of 
sternum until 8 
hours post-op 
Additional fluid 
given 
Mean ± SD 1199.04 ± 638.701 938.32 ± 736.151 0.062 
Osawa First 8 hours 
following ICU 
admission. 
 Fluid bolus Median (IQR) 1,000 mL IQR, 
625–1,500 
500 mL, (IQR) 500–1,000 <0.001 
Kapoor Induction to 8 
hours post-op 
Extra fluid 
administered 
Mean ± SD 376.33 ± 55.23 ml 343.33 ± 62.02 ml P = 0.003 
 
Note. GDT= Goal directed therapy; ICU=intensive care unit; IQR= interquartile range; SD= standard deviation. 
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Appendix F 
 
Cross Analysis of Outcomes of GDT Studies 
 
Table F-1 
Length of hospital stay/time to discharge 
 
First 
Author 
GDT/Study group Usual care/Control 
group 
P value 
Goepfert Time to reach discharge criteria: 5.3 ± 3.5 (5.0) 
days 
6.4 ± 3.3 (6.0) <0.001 
Fellahi Days (extremes) 8(6-58) 8(7-22) 0.727 
Thomson Median(IQR) 6(4) days  7(8) 0.004 
Parke Median(IQR) 6.2 (5–8) days 6.5 (6–8) 0.64 
Walker Not measured   
Shrestha Mean ± SD 7.64 ± 3.001days 9.10 ± 5.389 0.097 
Osawa Median (IQR)  9(8-16) days 12(9-22) 0.049 
Kapoor 7.17 ± 1.93 days 7.94 ± 1.64 0.025 
Note. GDT= Goal directed therapy; IQR= interquartile range. 
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Table F-2 
Length of ICU stay  
 
First 
Author 
GDT/Study group Usual care/Control group P value 
Goepfert 42.0 ± 18.7 (39.0) h 62.9 ± 58.2 [44.0] 0.018 
Fellahi 96 (38–425) hours 95 (41–480)  0.606 
Thomson Median 20 hours 24 hours 0.001 
Parke Median (IQR) 22.7 (20–46) hours 25.9 (21–48) 0.23 
Walker Median (IQR) 24.7 (22.1–46.85) hours 22.5 (14.5–29.25) 0.06 
Shrestha Mean ± SD 53.82 ± 29.727 hours 76.3 ± 37.768 0.089 
Osawa Median (IQR)  3(3-5) days 5(4-7) <0.001 
Kapoor 3.41 ± 0.75 days 3.74 ± 0.59 0.012 
Note. GDT= Goal directed therapy 
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Table F-3 
Mortality 
 
First 
Author 
GDT/Study group Usual care/Control 
group 
P value 
Goepfert None reported None reported  
Fellahi 1 2 0.605 
Thomson 2 (1.6%). 2(1.4%) 0.89 
Parke None reported 1 Not reported 
Walker 1 0 0.51 
Shrestha 2 3 0.653 
Osawa 3 (4.8) 6 (9.4) 0.49 
Kapoor 2 6 0.272 
Note. GDT= Goal directed therapy 
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Table F-4 
Complications  
 
First 
Author 
GDT/Study group Usual care/Control group P value 
Goepfert Total number of complications. 43 75 0.004 
Fellahi Total number of complications. 22 19 0.836 
 
Thomson Incidence of AKI   8(6.5%). 
Patients requiring dialysis 4(3.3%). 
Readmission to ICU 4(3.3%) 
28(19.9%) 
15(10.6%) 
13(9.2%) 
0.002 
0.021 
0.04 
Parke New onset atrial fibrillation 
 
 
AKI 
 No significant 
difference 
No significant 
difference 
Walker Reintubation  4/37 (10.8)  0/0 0.049 
Shrestha Wound complication 4  
Dialysis 3 
Re-operation 4 
Organ Dysfunction 0.44 (0- 4; total 15)  
8 
6 
6 
0.66 (0- 4; total 21) 
0.457 
0.468 
0.638 
0.592 
Osawa Infections 8 (12.9) 
Low cardiac output syndrome 4 (6.5) 
19 (29.7) 
17 (26.6) 
0.022 
0.002 
Kapoor Not reported   
Note. GDT= Goal directed therapy; AKI= Acute kidney injury. 
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Table F-5 
Time to extubation / duration of mechanical ventilation 
 
First 
Author 
GDT/Study group Usual care/Control 
group 
P value 
Goepfert Mean±SD (median)  10.8 ± 4.7 (10.0) hours 12.5 ± 6.0 (11.0) 0.12 
Fellahi 510 (360–1,110) minutes 570 (320–1,520) 0.005 
Thomson Not reported   
Parke 10.8 (9–15) hours 12.4 (9.1–23) 0.14 
Walker 14.5 (6.4–21.5) 11.5 (7–17) 0.27 
Shrestha 10.48 ± 7.640 hours 16.429 ± 11.801 0.041 
Osawa Median (IQR) 7.25 (5.5–9) hours 8.2 (6.6–11.5) 0.09 
Kapoor 18.05 ± 4.53 hours 19.89 ± 3.96 0.025 
Note. GDT= Goal directed therapy; SD= standard deviation; IQR= interquartile range. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      150 
Table F-6 
Use of inotropes/vasopressors 
 
First 
Author 
GDT/Study group Usual care/Control Group P value 
Goepfert Intra-op duration of norepinephrine use: 214 ± 110 (213) min 
Intra-op cumulative norepinephrine dosage 9.0 ± 7.6 (7.7) µg/kg 
278 ± 113 (283) min 
14.9 ± 11.1 (13.2) 
0.008 
0.002 
Fellahi No of patients receiving dobutamine: Number (%) 21 (44) 
No of patients receiving vasopressors: 16 (33) 
7 (16). 
13(30) 
0.003 
0.660 
Thomson Not reported   
Parke Use of vasoactive drugs  No significant 
difference 
Walker Use of  vasopressin 4 (10) 
Use of norepinephrine 8 (1.8–24.4) 
1 (2.5) 
5.6 (2.13–13.48) 
0.06 
0.28 
Shrestha Duration of use of inotropes: 23.2 ± 17.870 hrs 39.12 ± 18.615 0.032 
Osawa Cumulative ICU dobutamine dosage (mg/kg) 12 (6–22)  
Duration of dobutamine use (hrs) 54 (49–80)  
Cumulative ICU norepinephrine dosage (µg/kg) 0 (0–231)  
Duration of norepinephrine use (hrs) 0 (0–65)  
19 (11–31) 
76 (56–111) 
369 (0–1,051) 
78 (0–112) 
0.003 
0.001 
<0.001 
 0.001 
Kapoor Duration of inotrope use (SD)  2.81±(0.94) days 
Number of times inotropes adjusted (SD) 3.12± (0.80) 
3.09± (0.59) 
2.77±(0.91) 
0.063 
0.029 
Note. GDT= Goal directed therapy; SD= standard deviation; IQR= interquartile range; Min=minutes; Hrs=hours. 
 
